Filter (Type enter to validate)
  Cat_Number Product name Supplier Quantity Price Tech More
MSI500 Mer Cure (Stabilized Iodine Solution) Scy tek 500 ml 101 MSI500 Mer Cure (Stabilized Iodine Solution) Scy tek 500 ml 101
ASK
Publication
M1389 MarkerGene™ Cellular Senescence Assay Kit, Can be used to monitor and detect â galactosidase activity in senescent cells at pH 6.0 using X Gal, 1 kit MarkerGene 317 M1389 MarkerGene™ Cellular Senescence Assay Kit, Can be used to monitor and detect â galactosidase activity in senescent cells at pH 6.0 using X Gal, 1 kit MarkerGene 317
ASK
Publication
305-13451 Anti 3 DG imidazolone Monoclonal Antibody It has been shown that Advanced Glycation End products (AGEs) have been involved in chronic disease with aging, such as diabetes or brain disease. So far, sev B-Bridge 50 UG 958.65 305-13451 Anti 3 DG imidazolone Monoclonal Antibody It has been shown that Advanced Glycation End products (AGEs) have been involved in chronic disease with aging, such as diabetes or brain disease. So far, sev B-Bridge 50 UG 958.65
ASK
Publication
M1352 MarkerGene™ â Galactosidase Staining Kit, used to monitor and detect enzyme activity in stably or transiently transfected cells or transgenic tissues using X Gal, 1 kit MarkerGene 240 M1352 MarkerGene™ â Galactosidase Staining Kit, used to monitor and detect enzyme activity in stably or transiently transfected cells or transgenic tissues using X Gal, 1 kit MarkerGene 240
ASK
Publication
M1390 pNosdcGUS Plant GUS Expression Vector, This vector may be used to monitor virus production and transfection efficiency, 20 micrograms MarkerGene 362 M1390 pNosdcGUS Plant GUS Expression Vector, This vector may be used to monitor virus production and transfection efficiency, 20 micrograms MarkerGene 362
ASK
Publication
orb82514 FIV Core Ag, recombinant protein Feline Immunodeficiency Virus (FIV) Core Antigen, Recombinant is an infectious disease antigen toxin. For research use only. Biorb 100 768 orb82514 FIV Core Ag, recombinant protein Feline Immunodeficiency Virus (FIV) Core Antigen, Recombinant is an infectious disease antigen toxin. For research use only. Biorb 100 768
ASK
Publication
orb82396 Toxoplasma gondii GRA8, recombinant protein Toxoplasma gondii GRA8, Recombinant is an infectious disease antigen toxin. For research use only. Biorb 1 mg 784 orb82396 Toxoplasma gondii GRA8, recombinant protein Toxoplasma gondii GRA8, Recombinant is an infectious disease antigen toxin. For research use only. Biorb 1 mg 784
ASK
Publication
IPLA-DIBP Disease State Samples: Single Donor Human Diabetic Plasma Innovative Research INC 1ml 342 IPLA-DIBP Disease State Samples: Single Donor Human Diabetic Plasma Innovative Research INC 1ml 342 Publication
IPLA-ADPF Disease State Samples: Single Donor Human Atopic Dermatitis Plasma Innovative Research INC 1ml 342 IPLA-ADPF Disease State Samples: Single Donor Human Atopic Dermatitis Plasma Innovative Research INC 1ml 342
ASK
Publication
290-62601 Beta Amyloid (42) ELISA Kit, Human Rat Alzheimer''s Disease (AD) is characterized by the presence of extracellular senile plaques (SPs) and intracellular neurofibrillary tangles (NFT) in the brain. Th B-Bridge 96 tests 1040.55 290-62601 Beta Amyloid (42) ELISA Kit, Human Rat Alzheimer''s Disease (AD) is characterized by the presence of extracellular senile plaques (SPs) and intracellular neurofibrillary tangles (NFT) in the brain. Th B-Bridge 96 tests 1040.55
ASK
Publication
292-62301 Beta Amyloid (1 40) ELISA Kit, Human Alzheimer''s Disease (AD) is characterized by the presence of extracellular senile plaques (SPs) and intracellular neurofibrillary tangles (NFT) in the brain. The B-Bridge 96 tests 1040.55 292-62301 Beta Amyloid (1 40) ELISA Kit, Human Alzheimer''s Disease (AD) is characterized by the presence of extracellular senile plaques (SPs) and intracellular neurofibrillary tangles (NFT) in the brain. The B-Bridge 96 tests 1040.55
ASK
Publication
294-62501 Beta Amyloid (40) ELISA Kit, Human Rat Alzheimer''s Disease (AD) is characterized by the presence of extracellular senile plaques (SPs) and intracellular neurofibrillary tangles (NFT) in the brain. Th B-Bridge 96 tests 1040.55 294-62501 Beta Amyloid (40) ELISA Kit, Human Rat Alzheimer''s Disease (AD) is characterized by the presence of extracellular senile plaques (SPs) and intracellular neurofibrillary tangles (NFT) in the brain. Th B-Bridge 96 tests 1040.55
ASK
Publication
298-64601 Beta Amyloid (1 40) ELISA Kit II, Human Alzheimer''s Disease (AD) is characterized by the presence of extracellular senile plaques (SPs) and intracellular neurofibrillary tangles (NFT) in the brain. T B-Bridge 96 tests 1040.55 298-64601 Beta Amyloid (1 40) ELISA Kit II, Human Alzheimer''s Disease (AD) is characterized by the presence of extracellular senile plaques (SPs) and intracellular neurofibrillary tangles (NFT) in the brain. T B-Bridge 96 tests 1040.55
ASK
Publication
SFD241 Human soft tissue disease tissue array, 24 cases 24 cores US Biomax 166 SFD241 Human soft tissue disease tissue array, 24 cases 24 cores US Biomax 166
ASK
Publication
AR-0106-02 Newcastle Disease Virus (NDV) Real Time PCR Kit RNA III, IV Liferiver 25 349.65 AR-0106-02 Newcastle Disease Virus (NDV) Real Time PCR Kit RNA III, IV Liferiver 25 349.65
ASK
Publication
DS-MB-03442 Mouse Anti-Marek's Disease Virus Ray Biotech 200 604 DS-MB-03442 Mouse Anti-Marek's Disease Virus Ray Biotech 200 604
ASK
Publication
DS-MB-03465 Mouse Anti-Newcastle Disease Virus Ray Biotech 200 541 DS-MB-03465 Mouse Anti-Newcastle Disease Virus Ray Biotech 200 541
ASK
Publication
BRD181 Breast disease tissue array, 18 cases 18 cores US Biomax 118 BRD181 Breast disease tissue array, 18 cases 18 cores US Biomax 118
ASK
Publication
LUD151 Lung disease tissue array, 15 cases 15 cores US Biomax 166 LUD151 Lung disease tissue array, 15 cases 15 cores US Biomax 166
ASK
Publication
MD-05-0350 Mouse Anti-Newcastle Disease Virus (NDV) Antibodies Ray Biotech 1 mg 535 MD-05-0350 Mouse Anti-Newcastle Disease Virus (NDV) Antibodies Ray Biotech 1 mg 535 Publication
MD-14-0918 Mouse Anti-Marek Disease Virus Antibodies Ray Biotech 1 mg 568 MD-14-0918 Mouse Anti-Marek Disease Virus Antibodies Ray Biotech 1 mg 568
ASK
Publication
MD-14-1053 Rabbit Anti-B. burgdorferi (Lyme disease) Antibodies Ray Biotech 1 mL 386 MD-14-1053 Rabbit Anti-B. burgdorferi (Lyme disease) Antibodies Ray Biotech 1 mL 386
ASK
Publication
MD-14-1054 Rabbit Anti-B. burgdorferi (Lyme disease) Antibodies Ray Biotech 1 mL 386 MD-14-1054 Rabbit Anti-B. burgdorferi (Lyme disease) Antibodies Ray Biotech 1 mL 386
ASK
Publication
MD-14-1055 Rabbit Anti-B. burgdorferi (Lyme disease) Antibodies Ray Biotech 1 mL 370 MD-14-1055 Rabbit Anti-B. burgdorferi (Lyme disease) Antibodies Ray Biotech 1 mL 370
ASK
Publication
SKD241 Skin disease tissue array, 24 cases 24 cores US Biomax 166 SKD241 Skin disease tissue array, 24 cases 24 cores US Biomax 166
ASK
Publication
THD181 Thyroid disease tissue array, 18 cases 18 cores US Biomax 142 THD181 Thyroid disease tissue array, 18 cases 18 cores US Biomax 142
ASK
Publication
AGHIV-0210 rHIV gp36, insoluble Antigens - Infectious Disease Arista Bio 1-99 mg/ml/ea price x 2 510 AGHIV-0210 rHIV gp36, insoluble Antigens - Infectious Disease Arista Bio 1-99 mg/ml/ea price x 2 510
ASK
Publication
AGHIV-0215 rHIV gp36, soluble Antigens - Infectious Disease Arista Bio 1-99 mg/ml/ea price x 2 466 AGHIV-0215 rHIV gp36, soluble Antigens - Infectious Disease Arista Bio 1-99 mg/ml/ea price x 2 466
ASK
Publication
AGHIV-0225 rHIV gp41, soluble Antigens - Infectious Disease Arista Bio 1-99 mg/ml/ea price x 2 479 AGHIV-0225 rHIV gp41, soluble Antigens - Infectious Disease Arista Bio 1-99 mg/ml/ea price x 2 479
ASK
Publication
DID381 Digestive system disease tissue array, 38 cases 38 cores US Biomax 166 DID381 Digestive system disease tissue array, 38 cases 38 cores US Biomax 166
ASK
Publication
DS-MB-02741 Mouse Anti-Foot-and-Mouth Disease Virus Serotype O1 Ray Biotech 200 604 DS-MB-02741 Mouse Anti-Foot-and-Mouth Disease Virus Serotype O1 Ray Biotech 200 604
ASK
Publication
HND181 Head and neck disease tissue array, 18 cases 18 cores US Biomax 166 HND181 Head and neck disease tissue array, 18 cases 18 cores US Biomax 166
ASK
Publication
HNT961 Head and neck disease tissue array, 48 cases 96 cores US Biomax 225 HNT961 Head and neck disease tissue array, 48 cases 96 cores US Biomax 225
ASK
Publication
LUD481 Lung disease and normal tissue array, 16 cases 48 cores US Biomax 225 LUD481 Lung disease and normal tissue array, 16 cases 48 cores US Biomax 225
ASK
Publication
MD-14-0860 Mouse Anti-Foot and Mouth Disease Virus NS Antibodies Ray Biotech 1 mg 452 MD-14-0860 Mouse Anti-Foot and Mouth Disease Virus NS Antibodies Ray Biotech 1 mg 452
ASK
Publication
TH807 Thyroid disease spectrum tissue array, 75 cases 80 cores US Biomax 266 TH807 Thyroid disease spectrum tissue array, 75 cases 80 cores US Biomax 266
ASK
Publication
CVD231 Cardiovascular disease tissue array, non overlapping with CVD481, 23 cases 23 cores US Biomax 166 CVD231 Cardiovascular disease tissue array, non overlapping with CVD481, 23 cases 23 cores US Biomax 166
ASK
Publication
CVD481 Cardiovascular disease tissue array, no overlapping with CVD231, 24 cases 48 cores US Biomax 189 CVD481 Cardiovascular disease tissue array, no overlapping with CVD231, 24 cases 48 cores US Biomax 189
ASK
Publication
ES2081 Esophageal disease (progression) spectrum tissue array, 103 cases 208 cores US Biomax 456 ES2081 Esophageal disease (progression) spectrum tissue array, 103 cases 208 cores US Biomax 456
ASK
Publication
LP802 Laryngeal disease spectrum (progression) tissue array, 78 cases 80 cores US Biomax 278 LP802 Laryngeal disease spectrum (progression) tissue array, 78 cases 80 cores US Biomax 278
ASK
Publication
MD-14-0747 Mouse Anti-B. burgdorferi sensu stricto (Lyme disease) Antibodies Ray Biotech 1 mg 411 MD-14-0747 Mouse Anti-B. burgdorferi sensu stricto (Lyme disease) Antibodies Ray Biotech 1 mg 411
ASK
Publication
UGD381 Urinary genital system disease tissue array, 38 cases 38 cores US Biomax 166 UGD381 Urinary genital system disease tissue array, 38 cases 38 cores US Biomax 166
ASK
Publication
BC30013 Heart disease and normal tissue array, replacing BC30011, 18 cases 36 cores US Biomax 231 BC30013 Heart disease and normal tissue array, replacing BC30011, 18 cases 36 cores US Biomax 231
ASK
Publication
KD2084 Renal disease spectrum tissue array, with stage and TNM info, 104 cases 208 cores US Biomax 456 KD2084 Renal disease spectrum tissue array, with stage and TNM info, 104 cases 208 cores US Biomax 456
ASK
Publication
BL804 Bladder disease spectrum (urocystic cancer progression) tissue array, 80 cases 80 cores US Biomax 266 BL804 Bladder disease spectrum (urocystic cancer progression) tissue array, 80 cases 80 cores US Biomax 266
ASK
Publication
GA2081 Gallbladder disease spectrum (cholecystic cancer progression) tissue array, 103 cases 208 cores US Biomax 236 GA2081 Gallbladder disease spectrum (cholecystic cancer progression) tissue array, 103 cases 208 cores US Biomax 236
ASK
Publication
KD807 Kidney disease spectrum (renal cancer progression) tissue array, 80 cases 80 cores US Biomax 231 KD807 Kidney disease spectrum (renal cancer progression) tissue array, 80 cases 80 cores US Biomax 231
ASK
Publication
LC1201 Lung disease spectrum tissue array, 116 cases 120 cores, with grade and stage information US Biomax 278 LC1201 Lung disease spectrum tissue array, 116 cases 120 cores, with grade and stage information US Biomax 278
ASK
Publication
LC2083 Lung disease spectrum (pulmonary cancer progression) tissue array, 193 cases 208 cores US Biomax 456 LC2083 Lung disease spectrum (pulmonary cancer progression) tissue array, 193 cases 208 cores US Biomax 456
ASK
Publication
LC487 Lung disease spectrum tissue array, including TNM and pathology grade, 24 cases 48 cores US Biomax 225 LC487 Lung disease spectrum tissue array, including TNM and pathology grade, 24 cases 48 cores US Biomax 225
ASK
Publication
LC809 Lung disease spectrum (pulmonary cancer progression) tissue array, 78 cases 80 cores US Biomax 231 LC809 Lung disease spectrum (pulmonary cancer progression) tissue array, 78 cases 80 cores US Biomax 231
ASK
Publication
LV2081 Hepatic disease spectrum (liver cancer progression) tissue array, 103 cases 208 cores US Biomax 516 LV2081 Hepatic disease spectrum (liver cancer progression) tissue array, 103 cases 208 cores US Biomax 516
ASK
Publication
LV8011 Liver disease spectrum (hepatic cancer progression) tissue array, 76 cases 80 cores US Biomax 231 LV8011 Liver disease spectrum (hepatic cancer progression) tissue array, 76 cases 80 cores US Biomax 231
ASK
Publication
PR805 Prostate disease spectrum (prostatic cancer progression) tissue array, 80 cases 80 cores US Biomax 266 PR805 Prostate disease spectrum (prostatic cancer progression) tissue array, 80 cases 80 cores US Biomax 266
ASK
Publication
RE2081 Rectum disease spectrum (rectal cancer progression) tissue array, 98 cases 208 cores US Biomax 456 RE2081 Rectum disease spectrum (rectal cancer progression) tissue array, 98 cases 208 cores US Biomax 456
ASK
Publication
RE804 Rectal disease spectrum (rectum cancer progression) tissue array, 75 cases 80 cores US Biomax 231 RE804 Rectal disease spectrum (rectum cancer progression) tissue array, 75 cases 80 cores US Biomax 231
ASK
Publication
SK2081 Skin disease spectrum (dermatic cancer progression) tissue array, 102 cases 208 cores US Biomax 456 SK2081 Skin disease spectrum (dermatic cancer progression) tissue array, 102 cases 208 cores US Biomax 456
ASK
Publication
SK805 Skin disease spectrum (dermatic cancer progression) tissue array, 79 cases 80 cores US Biomax 266 SK805 Skin disease spectrum (dermatic cancer progression) tissue array, 79 cases 80 cores US Biomax 266
ASK
Publication
SM2081 Small intestine disease (cancer progression) spectrum tissue array, 95 cases 208 cores US Biomax 456 SM2081 Small intestine disease (cancer progression) spectrum tissue array, 95 cases 208 cores US Biomax 456
ASK
Publication
SP1001 Spleen disease spectrum (splenic cancer progression) tissue array, 50 cases 100 cores US Biomax 266 SP1001 Spleen disease spectrum (splenic cancer progression) tissue array, 50 cases 100 cores US Biomax 266
ASK
Publication
TE803 Testis disease spectrum (testicular cancer progression) tissue array, 80 cases 80 cores US Biomax 266 TE803 Testis disease spectrum (testicular cancer progression) tissue array, 80 cases 80 cores US Biomax 266
ASK
Publication
THY761 Thymus disease spectrum (thymic cancer progression) tissue array, 76 cases 76 cores US Biomax 266 THY761 Thymus disease spectrum (thymic cancer progression) tissue array, 76 cases 76 cores US Biomax 266
ASK
Publication
UV1001 Vulval disease spectrum (vulva cancer progression) tissue array, 46 cases 100 cores US Biomax 266 UV1001 Vulval disease spectrum (vulva cancer progression) tissue array, 46 cases 100 cores US Biomax 266
ASK
Publication
OR801 Parotid gland disease spectrum (parotidean cancer progression) tissue array, 80 cases 80 cores US Biomax 266 OR801 Parotid gland disease spectrum (parotidean cancer progression) tissue array, 80 cases 80 cores US Biomax 266
ASK
Publication
SO1001 Peripheral nerve disease spectrum (peripheroneural cancer progression) tissue array, 50 cases 100 cores US Biomax 266 SO1001 Peripheral nerve disease spectrum (peripheroneural cancer progression) tissue array, 50 cases 100 cores US Biomax 266
ASK
Publication
TE2081 Testis disease spectrum (testicular cancer progression) tissue array, with TNM data, 104 cases 208 cores US Biomax 456 TE2081 Testis disease spectrum (testicular cancer progression) tissue array, with TNM data, 104 cases 208 cores US Biomax 456
ASK
Publication
UR1001 Ureter and urethra disease spectrum tissue array, with stage, grade and TNM data, 50 cases 100 cores US Biomax 199 UR1001 Ureter and urethra disease spectrum tissue array, with stage, grade and TNM data, 50 cases 100 cores US Biomax 199
ASK
Publication
BC03002 Liver disease spectrum tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores US Biomax 266 BC03002 Liver disease spectrum tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores US Biomax 266
ASK
Publication
BC04002 Lung disease spectrum tissue array, including TNM, clinical stage and pathology grade, 99 cases 100 cores US Biomax 266 BC04002 Lung disease spectrum tissue array, including TNM, clinical stage and pathology grade, 99 cases 100 cores US Biomax 266
ASK
Publication
BC05002 Colon disease spectrum tissue array, including TNM, clinical stage and pathology grade, 79 cases 80 cores US Biomax 266 BC05002 Colon disease spectrum tissue array, including TNM, clinical stage and pathology grade, 79 cases 80 cores US Biomax 266
ASK
Publication
BR722 Breast disease spectrum tissue array, 66 cases 72 cores, including normal, precancerous and cancer in different stages US Biomax 231 BR722 Breast disease spectrum tissue array, 66 cases 72 cores, including normal, precancerous and cancer in different stages US Biomax 231
ASK
Publication
MC631 Multiple organ, diseased tissue array (63 cases 63 cores, 20 types of cancer and disease), replacing BC00014 US Biomax 160 MC631 Multiple organ, diseased tissue array (63 cases 63 cores, 20 types of cancer and disease), replacing BC00014 US Biomax 160
ASK
Publication
PR8011 Prostate disease spectrum tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing PR805 US Biomax 314 PR8011 Prostate disease spectrum tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing PR805 US Biomax 314
ASK
Publication
A80059Mu01 Antibody to Parkinson Disease Protein 7 (PARK7) Organism: Mus musculus (Mouse) Type: Polyclonal Source: Rabbit USCNLife 50ug 340 A80059Mu01 Antibody to Parkinson Disease Protein 7 (PARK7) Organism: Mus musculus (Mouse) Type: Polyclonal Source: Rabbit USCNLife 50ug 340
ASK
Publication
BR1003 Breast pre cancerous disease and cancer tissue array (100 cases 101 cores), with clinical stage and pathology grade data US Biomax 266 BR1003 Breast pre cancerous disease and cancer tissue array (100 cases 101 cores), with clinical stage and pathology grade data US Biomax 266
ASK
Publication
SK245 Skin disease tissue array, including TNM, clinical stage and pathology grade, 24 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105 SK245 Skin disease tissue array, including TNM, clinical stage and pathology grade, 24 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
BR963 Breast disease spectrum tissue array, including TNM and pathology grade, stage, TNM and IHC markers (AR, PR, ER, Her 2, Ki67, CK14 and p53), 48 cases 96 cores, replacing BR962 US Biomax 314 BR963 Breast disease spectrum tissue array, including TNM and pathology grade, stage, TNM and IHC markers (AR, PR, ER, Her 2, Ki67, CK14 and p53), 48 cases 96 cores, replacing BR962 US Biomax 314
ASK
Publication
BR480 Breast disease spectrum tissue array progression array, 48 cases 48 cores US Biomax 314 BR480 Breast disease spectrum tissue array progression array, 48 cases 48 cores US Biomax 314
ASK
Publication
LM801 Lymphoma (Hodgkin's and non Hodgkin's disease) tissue array, 80 cases 80 cores US Biomax 266 LM801 Lymphoma (Hodgkin's and non Hodgkin's disease) tissue array, 80 cases 80 cores US Biomax 266
ASK
Publication
BL2082 Bladder disease spectrum (bladder cancer progression) tissue array, 202 cases 208 cores US Biomax 456 BL2082 Bladder disease spectrum (bladder cancer progression) tissue array, 202 cases 208 cores US Biomax 456
ASK
Publication
BO2081 Bone disease spectrum (bone tumor progression) tissue array, 104 cases 208 cores US Biomax 516 BO2081 Bone disease spectrum (bone tumor progression) tissue array, 104 cases 208 cores US Biomax 516
ASK
Publication
BR2082 Breast disease spectrum (breast cancer progression) tissue array, 206 cases 208 cores US Biomax 456 BR2082 Breast disease spectrum (breast cancer progression) tissue array, 206 cases 208 cores US Biomax 456
ASK
Publication
CIN481 Cervical intraepithelial neoplasia tissue array with cervical disease spectrum, 48 cases 48 cores US Biomax 225 CIN481 Cervical intraepithelial neoplasia tissue array with cervical disease spectrum, 48 cases 48 cores US Biomax 225
ASK
Publication
CO808 Colon disease spectrum (colon cancer progression) tissue array, 76 cases 80 cores US Biomax 266 CO808 Colon disease spectrum (colon cancer progression) tissue array, 76 cases 80 cores US Biomax 266
ASK
Publication
ES809 Esophageal disease spectrum (esophageal cancer progression) tissue array, 78 cases 80 cores US Biomax 231 ES809 Esophageal disease spectrum (esophageal cancer progression) tissue array, 78 cases 80 cores US Biomax 231
ASK
Publication
GA801 Gallbladder disease spectrum (gallbladder cancer progression) tissue array, 80 cases 80 cores US Biomax 123 GA801 Gallbladder disease spectrum (gallbladder cancer progression) tissue array, 80 cases 80 cores US Biomax 123
ASK
Publication
HE1001 Heart disease spectrum (heart tumor progression) tissue array, 50 cases 100 cores US Biomax 266 HE1001 Heart disease spectrum (heart tumor progression) tissue array, 50 cases 100 cores US Biomax 266
ASK
Publication
LM802 Lymphoma (Hodgkin's and non Hodgkin's disease) tissue array, 80 cases 80 cores, replaced by NHL803 US Biomax 266 LM802 Lymphoma (Hodgkin's and non Hodgkin's disease) tissue array, 80 cases 80 cores, replaced by NHL803 US Biomax 266
ASK
Publication
NH1001 Nasopharynx disease spectrum (nasopharynx cancer progression) tissue array, 49 cases 100 cores US Biomax 266 NH1001 Nasopharynx disease spectrum (nasopharynx cancer progression) tissue array, 49 cases 100 cores US Biomax 266
ASK
Publication
OR1001 Tonsil disease spectrum (tonsil tumor progression) tissue array, 50 cases 100 cores US Biomax 266 OR1001 Tonsil disease spectrum (tonsil tumor progression) tissue array, 50 cases 100 cores US Biomax 266
ASK
Publication
PE601 Penis disease spectrum (penis tumor progression) tissue array, 59 cases 60 cores US Biomax 266 PE601 Penis disease spectrum (penis tumor progression) tissue array, 59 cases 60 cores US Biomax 266
ASK
Publication
ST1001 Stomach disease spectrum (stomach cancer progression) tissue array, 100 cases 100 cores US Biomax 266 ST1001 Stomach disease spectrum (stomach cancer progression) tissue array, 100 cases 100 cores US Biomax 266
ASK
Publication
UT801 Endometrial disease spectrum (endometrial cancer progression) tissue array, 80 cases 80 cores US Biomax 278 UT801 Endometrial disease spectrum (endometrial cancer progression) tissue array, 80 cases 80 cores US Biomax 278
ASK
Publication
AD2081 Adrenal gland disease spectrum (adrenal cancer progression) tissue array, 100 cases 200 cores US Biomax 456 AD2081 Adrenal gland disease spectrum (adrenal cancer progression) tissue array, 100 cases 200 cores US Biomax 456
ASK
Publication
OR2081 Oral cavity disease spectrum (oral cancer progression) tissue array, 98 cases 208 cores US Biomax 456 OR2081 Oral cavity disease spectrum (oral cancer progression) tissue array, 98 cases 208 cores US Biomax 456
ASK
Publication
ST8011 Gastric cardia disease spectrum (cardia cancer progression) tissue array, 80 cases 80 cores US Biomax 266 ST8011 Gastric cardia disease spectrum (cardia cancer progression) tissue array, 80 cases 80 cores US Biomax 266
ASK
Publication
BR963a Breast disease spectrum tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores, replacing BR963; ihc Anti-Actin confirmed US Biomax 296 BR963a Breast disease spectrum tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores, replacing BR963; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
OV1001 Ovarian disease spectrum (ovarian cancer progression) tissue array, 100 cases 100 cores, replaced by OV1005 US Biomax 231 OV1001 Ovarian disease spectrum (ovarian cancer progression) tissue array, 100 cases 100 cores, replaced by OV1005 US Biomax 231
ASK
Publication
SO8011 Smooth muscle and striated muscle disease spectrum (cancer progression) tissue array, 80 cases 80 cores US Biomax 278 SO8011 Smooth muscle and striated muscle disease spectrum (cancer progression) tissue array, 80 cases 80 cores US Biomax 278
ASK
Publication
BC06002 Rectum disease spectrum (rectum cancer progression) tissue array, including TNM and pathology grade, 63 cases 72 cores US Biomax 321 BC06002 Rectum disease spectrum (rectum cancer progression) tissue array, including TNM and pathology grade, 63 cases 72 cores US Biomax 321
ASK
Publication
BC07001 Kidney disease spectrum (kidney cancer progression) tissue array, including TNM and pathology grade, 40 cases 80 cores US Biomax 321 BC07001 Kidney disease spectrum (kidney cancer progression) tissue array, including TNM and pathology grade, 40 cases 80 cores US Biomax 321
ASK
Publication
CNS801 Brain disease spectrum (brain cancer progression) tissue array, with stage, TNM and grade info, 79 cases 80 cores US Biomax 314 CNS801 Brain disease spectrum (brain cancer progression) tissue array, with stage, TNM and grade info, 79 cases 80 cores US Biomax 314
ASK
Publication
CO2081 Colon disease spectrum (colon cancer progression) tissue array, including TNM and pathology grade, 103 cases 208 cores US Biomax 456 CO2081 Colon disease spectrum (colon cancer progression) tissue array, including TNM and pathology grade, 103 cases 208 cores US Biomax 456
ASK
Publication
PA2081 Pancreatic disease spectrum (pancreatic cancer progression) tissue array with pathology grade and TNM information, 101 cases 208 cores US Biomax 456 PA2081 Pancreatic disease spectrum (pancreatic cancer progression) tissue array with pathology grade and TNM information, 101 cases 208 cores US Biomax 456
ASK
Publication
CR601 Cervical carcinoma tissue array with cervical disease spectrum (normal, inflammation, CIN, malignant I III), 59 cases 60 cores, replaced by CR602 US Biomax 231 CR601 Cervical carcinoma tissue array with cervical disease spectrum (normal, inflammation, CIN, malignant I III), 59 cases 60 cores, replaced by CR602 US Biomax 231
ASK
Publication
LM208 High density tissue microarray of Hodgkin's Disease, Non Hodgkin's lymphoma and normal lymph node tissues, 69 cases 208 cores US Biomax 456 LM208 High density tissue microarray of Hodgkin's Disease, Non Hodgkin's lymphoma and normal lymph node tissues, 69 cases 208 cores US Biomax 456
ASK
Publication
OV1005a Ovary disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1005; ihc Anti-Actin confirmed US Biomax 267 OV1005a Ovary disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1005; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
MGS801 Male genitourinary system tissue array with normal, inflammation, disease and cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores US Biomax 266 MGS801 Male genitourinary system tissue array with normal, inflammation, disease and cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores US Biomax 266
ASK
Publication
OV1005 Ovarian disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1001 US Biomax 266 OV1005 Ovarian disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1001 US Biomax 266
ASK
Publication
SO2081 Muscle disease spectrum (smooth muscle and striated muscle cancer progression) tissue array, 104 cases 208 cores US Biomax 456 SO2081 Muscle disease spectrum (smooth muscle and striated muscle cancer progression) tissue array, 104 cases 208 cores US Biomax 456
ASK
Publication
BO801 Bone and cartilage disease spectrum (bone and cartilage cancer progression) tissue array, 80 cases 80 cores US Biomax 266 BO801 Bone and cartilage disease spectrum (bone and cartilage cancer progression) tissue array, 80 cases 80 cores US Biomax 266
ASK
Publication
CNS2081 Central nerve disease spectrum (central nerve tumor progression) tissue array, 104 cases 208 cores US Biomax 516 CNS2081 Central nerve disease spectrum (central nerve tumor progression) tissue array, 104 cases 208 cores US Biomax 516
ASK
Publication
OR802 Oral cavity disease spectrum (oral cavity cancer progression) tissue array, 79 cases 80 cores US Biomax 266 OR802 Oral cavity disease spectrum (oral cavity cancer progression) tissue array, 79 cases 80 cores US Biomax 266
ASK
Publication
SO8010 Blood vessel disease spectrum (blood vessel cancer progression) tissue array, 80 cases 80 cores US Biomax 266 SO8010 Blood vessel disease spectrum (blood vessel cancer progression) tissue array, 80 cases 80 cores US Biomax 266
ASK
Publication
UTE601 Fallopian tube disease spectrum (fallopian tube cancer progression) tissue array, 30 cases 60 cores US Biomax 266 UTE601 Fallopian tube disease spectrum (fallopian tube cancer progression) tissue array, 30 cases 60 cores US Biomax 266
ASK
Publication
VA1001 Vermiform appendix disease spectrum (vermiform appendix tumor progression) tissue array, 50 cases 100 cores US Biomax 266 VA1001 Vermiform appendix disease spectrum (vermiform appendix tumor progression) tissue array, 50 cases 100 cores US Biomax 266
ASK
Publication
SM802 Small intestine disease spectrum (small intestine cancer progression) tissue array, with grade, stage and TNM data, 72 cases 80 cores US Biomax 266 SM802 Small intestine disease spectrum (small intestine cancer progression) tissue array, with grade, stage and TNM data, 72 cases 80 cores US Biomax 266
ASK
Publication
SO2083 Adipose tissue disease spectrum (adipose tumor progression) tissue array, 104 cases 208 cores US Biomax 456 SO2083 Adipose tissue disease spectrum (adipose tumor progression) tissue array, 104 cases 208 cores US Biomax 456
ASK
Publication
CR602 Tissue array of uterine cervical disease spectrum (cervical cancer, CIN, inflammation and adjacent normal tissue), 60 cases 60 cores, replacing CR601 US Biomax 231 CR602 Tissue array of uterine cervical disease spectrum (cervical cancer, CIN, inflammation and adjacent normal tissue), 60 cases 60 cores, replacing CR601 US Biomax 231
ASK
Publication
SO2084 Fibrous tissue disease spectrum (fibrous tissue cancer progression) tissue array, 104 cases 208 cores US Biomax 456 SO2084 Fibrous tissue disease spectrum (fibrous tissue cancer progression) tissue array, 104 cases 208 cores US Biomax 456
ASK
Publication
SPR-131C Recombinant Mn SOD (Human) Protein, his tagged Species Human Expression system E. coli Stressmarq 2x 100ug 1278 SPR-131C Recombinant Mn SOD (Human) Protein, his tagged Species Human Expression system E. coli Stressmarq 2x 100ug 1278
ASK
Publication
8GSL1 Human enzymes and proteins Glycosylated Soluble LOX 1, Human, recombinant Hytest 0,1 mg 1147.35 8GSL1 Human enzymes and proteins Glycosylated Soluble LOX 1, Human, recombinant Hytest 0,1 mg 1147.35 Publication
1090A-100 Caspase-10 a, human recombinant CASP10 Human Biovision 100 units 306 1090A-100 Caspase-10 a, human recombinant CASP10 Human Biovision 100 units 306
ASK
Publication
1089P-50 Caspase-9 Proform, human recombinant Human Biovision 50 μg 342 1089P-50 Caspase-9 Proform, human recombinant Human Biovision 50 μg 342
ASK
Publication
1090B-100 Caspase-10 b, human recombinant Human Biovision 100 units 306 1090B-100 Caspase-10 b, human recombinant Human Biovision 100 units 306
ASK
Publication
073-04931 Growth Differentiation Factor 11, Human, recombinant (GDF 11 BMP 11) Source Human GDF 11cDNA expressed in E.coli Appearance Lyophilized form with no additives (Sterile filtered) Molecularweight 2 B-Bridge 20 ug 520.8 073-04931 Growth Differentiation Factor 11, Human, recombinant (GDF 11 BMP 11) Source Human GDF 11cDNA expressed in E.coli Appearance Lyophilized form with no additives (Sterile filtered) Molecularweight 2 B-Bridge 20 ug 520.8
ASK
Publication
1137-100 HAT (P/CAF), human recombinant Biovision 100 μg 322.245 1137-100 HAT (P/CAF), human recombinant Biovision 100 μg 322.245
ASK
Publication
1137-100 HAT (P CAF), human recombinant Biovision 100 ìg 325.08 1137-100 HAT (P CAF), human recombinant Biovision 100 ìg 325.08
ASK
Publication
228-10104-1 Recombinant Human Bcl-6 Ray Biotech 2 422 228-10104-1 Recombinant Human Bcl-6 Ray Biotech 2 422 Publication
228-10104-2 Recombinant Human Bcl-6 Ray Biotech 5 566 228-10104-2 Recombinant Human Bcl-6 Ray Biotech 5 566 Publication
228-10104-3 Recombinant Human Bcl-6 Ray Biotech 10 868 228-10104-3 Recombinant Human Bcl-6 Ray Biotech 10 868 Publication
228-10285-1 Recombinant Human C-SRC Ray Biotech 2 201 228-10285-1 Recombinant Human C-SRC Ray Biotech 2 201 Publication
228-10285-2 Recombinant Human C-SRC Ray Biotech 10 290 228-10285-2 Recombinant Human C-SRC Ray Biotech 10 290 Publication
228-10304-1 Recombinant Human D4-GDI Ray Biotech 2 422 228-10304-1 Recombinant Human D4-GDI Ray Biotech 2 422 Publication
228-10304-2 Recombinant Human D4-GDI Ray Biotech 5 566 228-10304-2 Recombinant Human D4-GDI Ray Biotech 5 566 Publication
228-10304-3 Recombinant Human D4-GDI Ray Biotech 10 868 228-10304-3 Recombinant Human D4-GDI Ray Biotech 10 868 Publication
228-10373-1 Recombinant Human ELK-1 Ray Biotech 2 201 228-10373-1 Recombinant Human ELK-1 Ray Biotech 2 201 Publication
228-10373-2 Recombinant Human ELK-1 Ray Biotech 10 290 228-10373-2 Recombinant Human ELK-1 Ray Biotech 10 290 Publication
228-10492-1 Recombinant Human FOS-B Ray Biotech 2 422 228-10492-1 Recombinant Human FOS-B Ray Biotech 2 422
ASK
Publication
228-10492-2 Recombinant Human FOS-B Ray Biotech 5 566 228-10492-2 Recombinant Human FOS-B Ray Biotech 5 566
ASK
Publication
228-10492-3 Recombinant Human FOS-B Ray Biotech 10 868 228-10492-3 Recombinant Human FOS-B Ray Biotech 10 868
ASK
Publication
228-10502-1 Recombinant Human Fyn-p59 Ray Biotech 2 422 228-10502-1 Recombinant Human Fyn-p59 Ray Biotech 2 422
ASK
Publication
228-10502-2 Recombinant Human Fyn-p59 Ray Biotech 5 566 228-10502-2 Recombinant Human Fyn-p59 Ray Biotech 5 566
ASK
Publication
228-10502-3 Recombinant Human Fyn-p59 Ray Biotech 10 868 228-10502-3 Recombinant Human Fyn-p59 Ray Biotech 10 868
ASK
Publication
228-10973-1 Recombinant Human IPP-POZ Ray Biotech 10 201 228-10973-1 Recombinant Human IPP-POZ Ray Biotech 10 201
ASK
Publication
228-10973-2 Recombinant Human IPP-POZ Ray Biotech 50 290 228-10973-2 Recombinant Human IPP-POZ Ray Biotech 50 290
ASK
Publication
228-10973-3 Recombinant Human IPP-POZ Ray Biotech 1 mg 2509 228-10973-3 Recombinant Human IPP-POZ Ray Biotech 1 mg 2509
ASK
Publication
228-11003-1 Recombinant Human Ku P70 P80 Ray Biotech 5 201 228-11003-1 Recombinant Human Ku P70 P80 Ray Biotech 5 201
ASK
Publication
228-11003-2 Recombinant Human Ku P70 P80 Ray Biotech 20 290 228-11003-2 Recombinant Human Ku P70 P80 Ray Biotech 20 290
ASK
Publication
228-11003-3 Recombinant Human Ku P70 P80 Ray Biotech 1 mg 3933 228-11003-3 Recombinant Human Ku P70 P80 Ray Biotech 1 mg 3933
ASK
Publication
228-11191-1 Recombinant Human p63 Ray Biotech 2 422 228-11191-1 Recombinant Human p63 Ray Biotech 2 422 Publication
228-11191-2 Recombinant Human p63 Ray Biotech 5 566 228-11191-2 Recombinant Human p63 Ray Biotech 5 566 Publication
228-11191-3 Recombinant Human p63 Ray Biotech 10 868 228-11191-3 Recombinant Human p63 Ray Biotech 10 868 Publication
228-11237-1 Recombinant Human PGR Ray Biotech 2 422 228-11237-1 Recombinant Human PGR Ray Biotech 2 422 Publication
228-11237-2 Recombinant Human PGR Ray Biotech 5 566 228-11237-2 Recombinant Human PGR Ray Biotech 5 566 Publication
228-11237-3 Recombinant Human PGR Ray Biotech 10 868 228-11237-3 Recombinant Human PGR Ray Biotech 10 868 Publication
228-11281-1 Recombinant Human PM Scl 100 Ray Biotech 5 201 228-11281-1 Recombinant Human PM Scl 100 Ray Biotech 5 201
ASK
Publication
228-11281-2 Recombinant Human PM Scl 100 Ray Biotech 20 290 228-11281-2 Recombinant Human PM Scl 100 Ray Biotech 20 290
ASK
Publication
228-11281-3 Recombinant Human PM Scl 100 Ray Biotech 1 mg 3933 228-11281-3 Recombinant Human PM Scl 100 Ray Biotech 1 mg 3933
ASK
Publication
4022-100 EGF, human recombinant Biovision 100 ìg 128 4022-100 EGF, human recombinant Biovision 100 ìg 128 Publication
4022-1000 EGF, human recombinant Biovision 1 mg 303 4022-1000 EGF, human recombinant Biovision 1 mg 303 Publication
4022-500 EGF, human recombinant Biovision 500 ìg 234 4022-500 EGF, human recombinant Biovision 500 ìg 234 Publication
4022-5000 EGF, human recombinant Biovision 5 mg 968 4022-5000 EGF, human recombinant Biovision 5 mg 968 Publication
4025-1000 ENA 78, human recombinant Biovision 1 mg 3891 4025-1000 ENA 78, human recombinant Biovision 1 mg 3891
ASK
Publication
4025-20 ENA-78, human recombinant Biovision 20 μg 247 4025-20 ENA-78, human recombinant Biovision 20 μg 247
ASK
Publication
4034-1000 FGF 1, human recombinant Biovision 1 mg 1536 4034-1000 FGF 1, human recombinant Biovision 1 mg 1536
ASK
Publication
4034-50 FGF-1, human recombinant Biovision 50 μg 236 4034-50 FGF-1, human recombinant Biovision 50 μg 236
ASK
Publication
4034-50 FGF 1, human recombinant Biovision 50 ìg 234 4034-50 FGF 1, human recombinant Biovision 50 ìg 234
ASK
Publication
4037-10 FGF 2, human recombinant Biovision 10 ìg 122 4037-10 FGF 2, human recombinant Biovision 10 ìg 122 Publication
4037-1000 FGF 2, human recombinant Biovision 1 mg 1332 4037-1000 FGF 2, human recombinant Biovision 1 mg 1332
ASK
Publication
4037-50 FGF 2, human recombinant Biovision 50 ìg 240 4037-50 FGF 2, human recombinant Biovision 50 ìg 240
ASK
Publication
4043-100 FGF-4, human recombinant Biovision 100 μg 661 4043-100 FGF-4, human recombinant Biovision 100 μg 661 Publication
4043-1000 FGF-4, human recombinant Biovision 1 mg 3379 4043-1000 FGF-4, human recombinant Biovision 1 mg 3379 Publication
4043-25 FGF-4, human recombinant Biovision 25 μg 241 4043-25 FGF-4, human recombinant Biovision 25 μg 241 Publication
4050-10 FGF-7 KGF, human recombinant Biovision 10 μg 236 4050-10 FGF-7 KGF, human recombinant Biovision 10 μg 236
ASK
Publication
4050-1000 FGF 7 KGF, human recombinant Biovision 1 mg 4812 4050-1000 FGF 7 KGF, human recombinant Biovision 1 mg 4812
ASK
Publication
4050-50 FGF 7 KGF, human recombinant Biovision 50 ug 943 4050-50 FGF 7 KGF, human recombinant Biovision 50 ug 943 Publication
4053-100 FGF-8, human recombinant Biovision 100 μg 661 4053-100 FGF-8, human recombinant Biovision 100 μg 661 Publication
4053-1000 FGF 8, human recombinant Biovision 1 mg 3072 4053-1000 FGF 8, human recombinant Biovision 1 mg 3072
ASK
Publication
4053-25 FGF-8, human recombinant Biovision 25 μg 236 4053-25 FGF-8, human recombinant Biovision 25 μg 236
ASK
Publication
4056-1000 FGF 9, human recombinant Biovision 1 mg 4403 4056-1000 FGF 9, human recombinant Biovision 1 mg 4403
ASK
Publication
4056-20 FGF 9, human recombinant Biovision 20 ug 284 4056-20 FGF 9, human recombinant Biovision 20 ug 284
ASK
Publication
4060-100 FGF-10 KGF-2, human recombinant Biovision 100 μg 559 4060-100 FGF-10 KGF-2, human recombinant Biovision 100 μg 559
ASK
Publication
4060-1000 FGF 10 KGF 2, human recombinant Biovision 1 mg 2919 4060-1000 FGF 10 KGF 2, human recombinant Biovision 1 mg 2919
ASK
Publication
4060-25 FGF-10 KGF-2, human recombinant Biovision 25 μg 236 4060-25 FGF-10 KGF-2, human recombinant Biovision 25 μg 236
ASK
Publication
4063-10 FGF-22, human recombinant Biovision 10 μg 266 4063-10 FGF-22, human recombinant Biovision 10 μg 266
ASK
Publication
4063-1000 FGF 22, human recombinant Biovision 1 mg 5631 4063-1000 FGF 22, human recombinant Biovision 1 mg 5631
ASK
Publication
4063-50 FGF-22, human recombinant Biovision 50 μg 764 4063-50 FGF-22, human recombinant Biovision 50 μg 764 Publication
4066-10 FGF-21, human recombinant Biovision 10 μg 241 4066-10 FGF-21, human recombinant Biovision 10 μg 241
ASK
Publication
4066-100 FGF-21, human recombinant Biovision 100 μg 661 4066-100 FGF-21, human recombinant Biovision 100 μg 661
ASK
Publication
4066-1000 FGF 21, human recombinant Biovision 1 mg 3942 4066-1000 FGF 21, human recombinant Biovision 1 mg 3942
ASK
Publication
4082-100 FGF-18, human recombinant Biovision 100 μg 559 4082-100 FGF-18, human recombinant Biovision 100 μg 559 Publication
4082-1000 FGF 18, human recombinant Biovision 1 mg 3072 4082-1000 FGF 18, human recombinant Biovision 1 mg 3072
ASK
Publication
4082-25 FGF-18, human recombinant Biovision 25 μg 241 4082-25 FGF-18, human recombinant Biovision 25 μg 241
ASK
Publication
4094-10 G CSF, human recombinant Biovision 10 ug 284 4094-10 G CSF, human recombinant Biovision 10 ug 284
ASK
Publication
4094-1000 G CSF, human recombinant Biovision 1 mg 4915 4094-1000 G CSF, human recombinant Biovision 1 mg 4915
ASK
Publication
4094-50 G CSF, human recombinant Biovision 50 ìg 603 4094-50 G CSF, human recombinant Biovision 50 ìg 603
ASK
Publication
4100-10 GM CSF, human recombinant Biovision 10 ug 284 4100-10 GM CSF, human recombinant Biovision 10 ug 284
ASK
Publication
4100-100 GM CSF, human recombinant Biovision 100 ìg 784 4100-100 GM CSF, human recombinant Biovision 100 ìg 784
ASK
Publication
4100-1000 GM CSF, human recombinant Biovision 1 mg 3123 4100-1000 GM CSF, human recombinant Biovision 1 mg 3123
ASK
Publication
4110-10 HCC 1, human recombinant Biovision 10 ug 284 4110-10 HCC 1, human recombinant Biovision 10 ug 284
ASK
Publication
4110-1000 HCC 1, human recombinant Biovision 1 mg 3993 4110-1000 HCC 1, human recombinant Biovision 1 mg 3993
ASK
Publication
4113-10 I 309, human recombinant Biovision 10 ug 284 4113-10 I 309, human recombinant Biovision 10 ug 284
ASK
Publication
4113-1000 I 309, human recombinant Biovision 1 mg 3993 4113-1000 I 309, human recombinant Biovision 1 mg 3993
ASK
Publication
4119-100 IGF I, human recombinant Biovision 100 ìg 133 4119-100 IGF I, human recombinant Biovision 100 ìg 133
ASK
Publication
4119-1000 IGF I, human recombinant Biovision 1 mg 272 4119-1000 IGF I, human recombinant Biovision 1 mg 272
ASK
Publication
4119-10MG IGF I, human recombinant Biovision 10 mg 1229 4119-10MG IGF I, human recombinant Biovision 10 mg 1229
ASK
Publication
4119-1G IGF I, human recombinant Biovision 1 g 35883 4119-1G IGF I, human recombinant Biovision 1 g 35883
ASK
Publication
4119-20MG IGF I, human recombinant Biovision 20 mg 1741 4119-20MG IGF I, human recombinant Biovision 20 mg 1741
ASK
Publication
4119-5000 IGF I, human recombinant Biovision 5 mg 764 4119-5000 IGF I, human recombinant Biovision 5 mg 764
ASK
Publication
4119-50MG IGF I, human recombinant Biovision 50 mg 3072 4119-50MG IGF I, human recombinant Biovision 50 mg 3072
ASK
Publication
4122-10 IGF-II, human recombinant Biovision 10 μg 134 4122-10 IGF-II, human recombinant Biovision 10 μg 134 Publication
4122-1000 IGF II, human recombinant Biovision 1 mg 1485 4122-1000 IGF II, human recombinant Biovision 1 mg 1485
ASK
Publication
4122-50 IGF II, human recombinant Biovision 50 ìg 234 4122-50 IGF II, human recombinant Biovision 50 ìg 234
ASK
Publication
4131-10 IL-2, human recombinant Biovision 10 μg 129 4131-10 IL-2, human recombinant Biovision 10 μg 129 Publication
4131-1000 IL 2, human recombinant Biovision 1 mg 1071 4131-1000 IL 2, human recombinant Biovision 1 mg 1071
ASK
Publication
4131-50 IL-2, human recombinant Biovision 50 μg 236 4131-50 IL-2, human recombinant Biovision 50 μg 236
ASK
Publication
4134-10 IL 3, human recombinant Biovision 10 ug 284 4134-10 IL 3, human recombinant Biovision 10 ug 284
ASK
Publication
4134-1000 IL 3, human recombinant Biovision 1 mg 2970 4134-1000 IL 3, human recombinant Biovision 1 mg 2970
ASK
Publication
4134-50 IL 3, human recombinant Biovision 50 ug 815 4134-50 IL 3, human recombinant Biovision 50 ug 815
ASK
Publication
4137-10 IL-4, human recombinant Biovision 10 μg 236 4137-10 IL-4, human recombinant Biovision 10 μg 236
ASK
Publication
4137-1000 IL 4, human recombinant Biovision 1 mg 3738 4137-1000 IL 4, human recombinant Biovision 1 mg 3738
ASK
Publication
4137-50 IL-4, human recombinant Biovision 50 μg 559 4137-50 IL-4, human recombinant Biovision 50 μg 559 Publication
4140-10 IL 5, human recombinant Biovision 10 ug 321 4140-10 IL 5, human recombinant Biovision 10 ug 321
ASK
Publication
4140-1000 IL 5, human recombinant Biovision 1 mg 5120 4140-1000 IL 5, human recombinant Biovision 1 mg 5120
ASK
Publication
4143-100 IL 6,human recombinant Biovision 100 ug 687 4143-100 IL 6,human recombinant Biovision 100 ug 687
ASK
Publication
4143-1000 IL-6, human recombinant Biovision 1 mg 2867 4143-1000 IL-6, human recombinant Biovision 1 mg 2867
ASK
Publication
4143-20 IL-6, human recombinant Biovision 20 μg 247 4143-20 IL-6, human recombinant Biovision 20 μg 247
ASK
Publication
4146-10 IL-7, human recombinant Biovision 10 μg 236 4146-10 IL-7, human recombinant Biovision 10 μg 236
ASK
Publication
4146-1000 IL 7, human recombinant Biovision 1 mg 5120 4146-1000 IL 7, human recombinant Biovision 1 mg 5120
ASK
Publication
4149-1000 IL 8 (77 a.a.), human recombinant Biovision 1 mg 3123 4149-1000 IL 8 (77 a.a.), human recombinant Biovision 1 mg 3123
ASK
Publication
4149-25 IL 8 (77 a.a.), human recombinant Biovision 25 ìg 234 4149-25 IL 8 (77 a.a.), human recombinant Biovision 25 ìg 234
ASK
Publication
4149M-1000 IL 8 (72 a.a.), human recombinant Biovision 1 mg 3123 4149M-1000 IL 8 (72 a.a.), human recombinant Biovision 1 mg 3123
ASK
Publication
4149M-25 IL 8 (72 a.a.), human recombinant Biovision 25 ìg 234 4149M-25 IL 8 (72 a.a.), human recombinant Biovision 25 ìg 234
ASK
Publication
4152-10 IL-9, human recombinant Biovision 10 μg 236 4152-10 IL-9, human recombinant Biovision 10 μg 236
ASK
Publication
4152-1000 IL 9, human recombinant Biovision 1 mg 5376 4152-1000 IL 9, human recombinant Biovision 1 mg 5376
ASK
Publication
4152-50 IL-9, human recombinant Biovision 50 μg 661 4152-50 IL-9, human recombinant Biovision 50 μg 661 Publication
4155-10 IL 10, human recombinant Biovision 10 ug 284 4155-10 IL 10, human recombinant Biovision 10 ug 284
ASK
Publication
4155-1000 IL 10, human recombinant Biovision 1 mg 4966 4155-1000 IL 10, human recombinant Biovision 1 mg 4966
ASK
Publication
4158-10 IL-11, human recombinant Biovision 10 μg 236 4158-10 IL-11, human recombinant Biovision 10 μg 236
ASK
Publication
4158-1000 IL 11, human recombinant Biovision 1 mg 4966 4158-1000 IL 11, human recombinant Biovision 1 mg 4966
ASK
Publication
4161-10 IL 12, human recombinant Biovision 10 ìg 245 4161-10 IL 12, human recombinant Biovision 10 ìg 245
ASK
Publication
4161-100 IL-12, human recombinant Biovision 100 μg 1588 4161-100 IL-12, human recombinant Biovision 100 μg 1588
ASK
Publication
4164-10 IL-13, human recombinant Biovision 10 μg 236 4164-10 IL-13, human recombinant Biovision 10 μg 236
ASK
Publication
4164-1000 IL 13, human recombinant Biovision 1 mg 5376 4164-1000 IL 13, human recombinant Biovision 1 mg 5376
ASK
Publication
4164-50 IL-13, human recombinant Biovision 50 μg 661 4164-50 IL-13, human recombinant Biovision 50 μg 661 Publication
4170-10 IL-15, human recombinant Biovision 10 μg 236 4170-10 IL-15, human recombinant Biovision 10 μg 236
ASK
Publication
4170-1000 IL 15, human recombinant Biovision 1 mg 3942 4170-1000 IL 15, human recombinant Biovision 1 mg 3942
ASK
Publication
4170-50 IL-15, human recombinant Biovision 50 μg 661 4170-50 IL-15, human recombinant Biovision 50 μg 661 Publication
4173-10 IL-16, human recombinant Biovision 10 μg 236 4173-10 IL-16, human recombinant Biovision 10 μg 236
ASK
Publication
4173-1000 IL 16, human recombinant Biovision 1 mg 4812 4173-1000 IL 16, human recombinant Biovision 1 mg 4812
ASK
Publication
4176-1000 IL 17A, human recombinant Biovision 1 mg 3072 4176-1000 IL 17A, human recombinant Biovision 1 mg 3072 Publication
4176-25 IL-17A, human recombinant Biovision 25 μg 236 4176-25 IL-17A, human recombinant Biovision 25 μg 236 Publication
4176AF-10 IL-17A F, human recombinant Biovision 10 μg 303 4176AF-10 IL-17A F, human recombinant Biovision 10 μg 303 Publication
4176AF-1000 IL 17A F, human recombinant Biovision 1 mg 5785 4176AF-1000 IL 17A F, human recombinant Biovision 1 mg 5785 Publication
4176AF-50 IL-17A F, human recombinant Biovision 50 μg 922 4176AF-50 IL-17A F, human recombinant Biovision 50 μg 922 Publication
4176E-1000 IL 17E, human recombinant Biovision 1 mg 3482 4176E-1000 IL 17E, human recombinant Biovision 1 mg 3482
ASK
Publication
4176E-25 IL 17E, human recombinant Biovision 25 ug 290 4176E-25 IL 17E, human recombinant Biovision 25 ug 290
ASK
Publication
4176F-1000 IL 17F, human recombinant Biovision 1 mg 3072 4176F-1000 IL 17F, human recombinant Biovision 1 mg 3072 Publication
4176F-25 IL 17F, human recombinant Biovision 25 ug 290 4176F-25 IL 17F, human recombinant Biovision 25 ug 290 Publication
4179-100 IL-18, human recombinant Biovision 100 μg 589 4179-100 IL-18, human recombinant Biovision 100 μg 589 Publication
4179-1000 IL 18, human recombinant Biovision 1 mg 3738 4179-1000 IL 18, human recombinant Biovision 1 mg 3738 Publication
4179-25 IL-18, human recombinant Biovision 25 μg 252 4179-25 IL-18, human recombinant Biovision 25 μg 252
ASK
Publication
4182-10 IL-21, human recombinant Biovision 10 μg 247 4182-10 IL-21, human recombinant Biovision 10 μg 247 Publication
4182-10 IL 21, human recombinant Biovision 10 ug 284.048 4182-10 IL 21, human recombinant Biovision 10 ug 284.048 Publication
4182-1000 IL 21, human recombinant Biovision 1 mg 4812 4182-1000 IL 21, human recombinant Biovision 1 mg 4812
ASK
Publication
4182-50 IL-21, human recombinant Biovision 50 μg 733 4182-50 IL-21, human recombinant Biovision 50 μg 733
ASK
Publication
4193-10 IL 33, human recombinant Biovision 10 ug 284 4193-10 IL 33, human recombinant Biovision 10 ug 284
ASK
Publication
4193-1000 IL 33, human recombinant Biovision 1 mg 5631 4193-1000 IL 33, human recombinant Biovision 1 mg 5631
ASK
Publication
4200-1000 IP 10, human recombinant Biovision 1 mg 3482 4200-1000 IP 10, human recombinant Biovision 1 mg 3482
ASK
Publication
4200-25 IP 10, human recombinant Biovision 25 ìg 234 4200-25 IP 10, human recombinant Biovision 25 ìg 234
ASK
Publication
4203-1000 I TAC, human recombinant Biovision 1 mg 3482 4203-1000 I TAC, human recombinant Biovision 1 mg 3482
ASK
Publication
4203-20 I TAC, human recombinant Biovision 20 ìg 234 4203-20 I TAC, human recombinant Biovision 20 ìg 234
ASK
Publication
4225-10 MCP-2, human recombinant Biovision 10 μg 247 4225-10 MCP-2, human recombinant Biovision 10 μg 247
ASK
Publication
4225-1000 MCP 2, human recombinant Biovision 1 mg 4096 4225-1000 MCP 2, human recombinant Biovision 1 mg 4096
ASK
Publication
4228-10 MCP-3, human recombinant Biovision 10 μg 247 4228-10 MCP-3, human recombinant Biovision 10 μg 247
ASK
Publication
4228-1000 MCP 3, human recombinant Biovision 1 mg 4096 4228-1000 MCP 3, human recombinant Biovision 1 mg 4096
ASK
Publication
4231-10 MCP-4, human recombinant Biovision 10 μg 247 4231-10 MCP-4, human recombinant Biovision 10 μg 247
ASK
Publication
4231-1000 MCP 4, human recombinant Biovision 1 mg 4096 4231-1000 MCP 4, human recombinant Biovision 1 mg 4096
ASK
Publication
4237-10 M CSF, human recombinant Biovision 10 ug 284 4237-10 M CSF, human recombinant Biovision 10 ug 284
ASK
Publication
4237-1000 M CSF, human recombinant Biovision 1 mg 4812 4237-1000 M CSF, human recombinant Biovision 1 mg 4812
ASK
Publication
4237-50 M-CSF, human recombinant Biovision 50 μg 661 4237-50 M-CSF, human recombinant Biovision 50 μg 661 Publication
4240-1000 MIG, human recombinant Biovision 1 mg 4096 4240-1000 MIG, human recombinant Biovision 1 mg 4096
ASK
Publication
4240-20 MIG, human recombinant Biovision 20 μg 266 4240-20 MIG, human recombinant Biovision 20 μg 266
ASK
Publication
4263-100 IL-1RA, human recombinant Biovision 100 μg 249 4263-100 IL-1RA, human recombinant Biovision 100 μg 249 Publication
4263-1000 IL-1RA, human recombinant Biovision 1 mg 1710 4263-1000 IL-1RA, human recombinant Biovision 1 mg 1710 Publication
4263-20 IL-1 RA, human recombinant Biovision 20 μg 139 4263-20 IL-1 RA, human recombinant Biovision 20 μg 139 Publication
4306-10 NT-3, human recombinant Biovision 10 μg 247 4306-10 NT-3, human recombinant Biovision 10 μg 247
ASK
Publication
4306-1000 NT 3, human recombinant Biovision 1 mg 4812 4306-1000 NT 3, human recombinant Biovision 1 mg 4812
ASK
Publication
4306-50 NT-3, human recombinant Biovision 50 μg 661 4306-50 NT-3, human recombinant Biovision 50 μg 661 Publication
4309-10 NT-4, human recombinant Biovision 10 μg 247 4309-10 NT-4, human recombinant Biovision 10 μg 247
ASK
Publication
4309-1000 NT 4, human recombinant Biovision 1 mg 4812 4309-1000 NT 4, human recombinant Biovision 1 mg 4812
ASK
Publication
4309-50 NT 4, human recombinant Biovision 50 ug 815 4309-50 NT 4, human recombinant Biovision 50 ug 815
ASK
Publication
4324-10 Apo-SAA, human recombinant Biovision 10 μg 134 4324-10 Apo-SAA, human recombinant Biovision 10 μg 134 Publication
4324-1000 Apo SAA, human recombinant Biovision 1 mg 1434 4324-1000 Apo SAA, human recombinant Biovision 1 mg 1434
ASK
Publication
4324-50 Apo-SAA, human recombinant Biovision 50 μg 236 4324-50 Apo-SAA, human recombinant Biovision 50 μg 236
ASK
Publication
4324-500 Apo-SAA, human recombinant Biovision 500 μg 968 4324-500 Apo-SAA, human recombinant Biovision 500 μg 968
ASK
Publication
4326-10 Apo D, human recombinant Biovision 10 ug 347 4326-10 Apo D, human recombinant Biovision 10 ug 347 Publication
4326-1000 Apo D, human recombinant Biovision 1 mg 6706 4326-1000 Apo D, human recombinant Biovision 1 mg 6706 Publication
4327-10 SCF, human recombinant Biovision 10 μg 247 4327-10 SCF, human recombinant Biovision 10 μg 247
ASK
Publication
4327-1000 SCF, human recombinant Biovision 1 mg 3482 4327-1000 SCF, human recombinant Biovision 1 mg 3482
ASK
Publication
4327-50 SCF, human recombinant Biovision 50 μg 559 4327-50 SCF, human recombinant Biovision 50 μg 559
ASK
Publication
4351-10 TPO, human recombinant Biovision 10 ìg 234 4351-10 TPO, human recombinant Biovision 10 ìg 234
ASK
Publication
4351-1000 TPO, human recombinant Biovision 1 mg 4045 4351-1000 TPO, human recombinant Biovision 1 mg 4045
ASK
Publication
4351-50 TPO, human recombinant Biovision 50 ìg 571 4351-50 TPO, human recombinant Biovision 50 ìg 571
ASK
Publication
4372-1000 BD 2, human recombinant Biovision 1 mg 3635 4372-1000 BD 2, human recombinant Biovision 1 mg 3635
ASK
Publication
4372-20 BD 2, human recombinant Biovision 20 ug 284 4372-20 BD 2, human recombinant Biovision 20 ug 284
ASK
Publication
4376-100 EBI-3, human recombinant Biovision 100 μg 764 4376-100 EBI-3, human recombinant Biovision 100 μg 764 Publication
4376-1000 EBI-3, human recombinant Biovision 1 mg 5376 4376-1000 EBI-3, human recombinant Biovision 1 mg 5376 Publication
4376-20 EBI-3, human recombinant Biovision 20 μg 241 4376-20 EBI-3, human recombinant Biovision 20 μg 241 Publication
4381-1000 NAP 2, human recombinant Biovision 1 mg 4096 4381-1000 NAP 2, human recombinant Biovision 1 mg 4096
ASK
Publication
4448-1000 TNF RII, human recombinant Biovision 1 mg 3482 4448-1000 TNF RII, human recombinant Biovision 1 mg 3482 Publication
4448-20 TNF RII, human recombinant Biovision 20 ug 296 4448-20 TNF RII, human recombinant Biovision 20 ug 296 Publication
4506-1000 BD 1, human recombinant Biovision 1 mg 3072 4506-1000 BD 1, human recombinant Biovision 1 mg 3072 Publication
4506-20 BD-1, human recombinant Biovision 20 μg 247 4506-20 BD-1, human recombinant Biovision 20 μg 247 Publication
4509-10 HGF, human recombinant Biovision 10 ug 284 4509-10 HGF, human recombinant Biovision 10 ug 284
ASK
Publication
4509-1000 HGF, human recombinant Biovision 1 mg 8382 4509-1000 HGF, human recombinant Biovision 1 mg 8382
ASK
Publication
4510-10 HGF, human recombinant Biovision 10 μg 247 4510-10 HGF, human recombinant Biovision 10 μg 247 Publication
4510-1000 HGF, human recombinant Biovision 1 mg 7730 4510-1000 HGF, human recombinant Biovision 1 mg 7730 Publication
4510-50 HGF, human recombinant Biovision 50 ìg 678 4510-50 HGF, human recombinant Biovision 50 ìg 678 Publication
4524-1000 BD 3, human recombinant Biovision 1 mg 3021 4524-1000 BD 3, human recombinant Biovision 1 mg 3021
ASK
Publication
4524-20 BD-3, human recombinant Biovision 20 μg 236 4524-20 BD-3, human recombinant Biovision 20 μg 236
ASK
Publication
4525-1000 BD-4, human recombinant Biovision 1 mg 3021 4525-1000 BD-4, human recombinant Biovision 1 mg 3021 Publication
4525-20 BD-4, human recombinant Biovision 20 μg 247 4525-20 BD-4, human recombinant Biovision 20 μg 247 Publication
4542-100 FGF 19, human recombinant Biovision 100 ìg 571 4542-100 FGF 19, human recombinant Biovision 100 ìg 571 Publication
4542-1000 FGF 19, human recombinant Biovision 1 mg 3072 4542-1000 FGF 19, human recombinant Biovision 1 mg 3072
ASK
Publication
4542-25 FGF-19, human recombinant Biovision 25 μg 247 4542-25 FGF-19, human recombinant Biovision 25 μg 247
ASK
Publication
4545-10 IL-19, human recombinant Biovision 10 μg 236 4545-10 IL-19, human recombinant Biovision 10 μg 236
ASK
Publication
4545-1000 IL 19, human recombinant Biovision 1 mg 5376 4545-1000 IL 19, human recombinant Biovision 1 mg 5376
ASK
Publication
4548-10 IL-20, human recombinant Biovision 10 μg 236 4548-10 IL-20, human recombinant Biovision 10 μg 236
ASK
Publication
4548-1000 IL 20, human recombinant Biovision 1 mg 4096 4548-1000 IL 20, human recombinant Biovision 1 mg 4096
ASK
Publication
4548-50 IL-20, human recombinant Biovision 50 μg 661 4548-50 IL-20, human recombinant Biovision 50 μg 661 Publication
4570-20 GDF-15-D, human recombinant Biovision 20 μg 247 4570-20 GDF-15-D, human recombinant Biovision 20 μg 247 Publication
4572-100 BMP-12 GDF-7, human recombinant Biovision 100 μg 559 4572-100 BMP-12 GDF-7, human recombinant Biovision 100 μg 559 Publication
4572-1000 BMP 12 GDF 7, human recombinant Biovision 1 mg 3789 4572-1000 BMP 12 GDF 7, human recombinant Biovision 1 mg 3789 Publication
4572-20 BMP-12 GDF-7, human recombinant Biovision 20 μg 247 4572-20 BMP-12 GDF-7, human recombinant Biovision 20 μg 247 Publication
4573-10 BMP-3, human recombinant Biovision 10 μg 134 4573-10 BMP-3, human recombinant Biovision 10 μg 134 Publication
4573-1000 BMP 3, human recombinant Biovision 1 mg 1588 4573-1000 BMP 3, human recombinant Biovision 1 mg 1588 Publication
4573-50 BMP-3, human recombinant Biovision 50 μg 252 4573-50 BMP-3, human recombinant Biovision 50 μg 252 Publication
4574-10 BMP-5, human recombinant Biovision 10 μg 236 4574-10 BMP-5, human recombinant Biovision 10 μg 236 Publication
4574-1000 BMP 5, human recombinant Biovision 1 mg 3072 4574-1000 BMP 5, human recombinant Biovision 1 mg 3072 Publication
4574-50 BMP 5, human recombinant Biovision 50 ìg 357 4574-50 BMP 5, human recombinant Biovision 50 ìg 357 Publication
4576-10 BMP-11, human recombinant Biovision 10 μg 236 4576-10 BMP-11, human recombinant Biovision 10 μg 236 Publication
4576-1000 BMP 11, human recombinant Biovision 1 mg 3072 4576-1000 BMP 11, human recombinant Biovision 1 mg 3072 Publication
4576-50 BMP 11, human recombinant Biovision 50 ìg 389 4576-50 BMP 11, human recombinant Biovision 50 ìg 389 Publication
4577-10 BMP-2, human recombinant Biovision 10 μg 247 4577-10 BMP-2, human recombinant Biovision 10 μg 247
ASK
Publication
4577-1000 BMP 2, human recombinant Biovision 1 mg 4505 4577-1000 BMP 2, human recombinant Biovision 1 mg 4505
ASK
Publication
4577-50 BMP 2, human recombinant Biovision 50 ìg 603 4577-50 BMP 2, human recombinant Biovision 50 ìg 603
ASK
Publication
4578-10 BMP-4, human recombinant Biovision 10 μg 236 4578-10 BMP-4, human recombinant Biovision 10 μg 236
ASK
Publication
4578-1000 BMP 4, human recombinant Biovision 1 mg 3738 4578-1000 BMP 4, human recombinant Biovision 1 mg 3738
ASK
Publication
4578-50 BMP-4, human recombinant Biovision 50 μg 559 4578-50 BMP-4, human recombinant Biovision 50 μg 559
ASK
Publication
4579-10 BMP-7, human recombinant Biovision 10 μg 236 4579-10 BMP-7, human recombinant Biovision 10 μg 236
ASK
Publication
4579-1000 BMP 7, human recombinant Biovision 1 mg 4096 4579-1000 BMP 7, human recombinant Biovision 1 mg 4096
ASK
Publication
4579-50 BMP 7, human recombinant Biovision 50 ìg 571 4579-50 BMP 7, human recombinant Biovision 50 ìg 571
ASK
Publication
4581-100 BMP-10, human recombinant Biovision 100 μg 559 4581-100 BMP-10, human recombinant Biovision 100 μg 559 Publication
4581-1000 BMP 10, human recombinant Biovision 1 mg 4096 4581-1000 BMP 10, human recombinant Biovision 1 mg 4096 Publication
4581-20 BMP-10, human recombinant Biovision 20 μg 236 4581-20 BMP-10, human recombinant Biovision 20 μg 236 Publication
4589-100 FGF-20, human recombinant Biovision 100 μg 764 4589-100 FGF-20, human recombinant Biovision 100 μg 764 Publication
4589-20 FGF-20, human recombinant Biovision 20 μg 266 4589-20 FGF-20, human recombinant Biovision 20 μg 266 Publication
4601-10 IL-22, human recombinant Biovision 10 μg 236 4601-10 IL-22, human recombinant Biovision 10 μg 236 Publication
4601-1000 IL 22, human recombinant Biovision 1 mg 5376 4601-1000 IL 22, human recombinant Biovision 1 mg 5376 Publication
4639-10 BMP-13, human recombinant Biovision 10 μg 129 4639-10 BMP-13, human recombinant Biovision 10 μg 129
ASK
Publication
4639-1000 BMP 13, human recombinant Biovision 1 mg 1536 4639-1000 BMP 13, human recombinant Biovision 1 mg 1536
ASK
Publication
4639-50 BMP-13, human recombinant Biovision 50 μg 247 4639-50 BMP-13, human recombinant Biovision 50 μg 247
ASK
Publication
4650-1000 PTH, human recombinant Biovision 1 mg 2048 4650-1000 PTH, human recombinant Biovision 1 mg 2048
ASK
Publication
4650-50 PTH, human recombinant Biovision 50 μg 252 4650-50 PTH, human recombinant Biovision 50 μg 252
ASK
Publication
4667-10 GDF-5, human recombinant Biovision 10 μg 129 4667-10 GDF-5, human recombinant Biovision 10 μg 129 Publication
4667-1000 GDF 5, human recombinant Biovision 1 mg 1588 4667-1000 GDF 5, human recombinant Biovision 1 mg 1588 Publication
4667-50 GDF 5, human recombinant Biovision 50 ug 284 4667-50 GDF 5, human recombinant Biovision 50 ug 284
ASK
Publication
4717-100 IGF BP1, human recombinant Biovision 100 ug 687 4717-100 IGF BP1, human recombinant Biovision 100 ug 687 Publication
4717-1000 IGF BP1, human recombinant Biovision 1 mg 2970 4717-1000 IGF BP1, human recombinant Biovision 1 mg 2970
ASK
Publication
4717-25 IGF-BP1, human recombinant Biovision 25 μg 247 4717-25 IGF-BP1, human recombinant Biovision 25 μg 247
ASK
Publication
4720-100 IGF-BP3, human recombinant Biovision 100 μg 589 4720-100 IGF-BP3, human recombinant Biovision 100 μg 589 Publication
4720-1000 IGF BP3, human recombinant Biovision 1 mg 2970 4720-1000 IGF BP3, human recombinant Biovision 1 mg 2970
ASK
Publication
4720-25 IGF-BP3, human recombinant Biovision 25 μg 247 4720-25 IGF-BP3, human recombinant Biovision 25 μg 247
ASK
Publication
4723-100 IGF BP5, human recombinant Biovision 100 ìg 603 4723-100 IGF BP5, human recombinant Biovision 100 ìg 603 Publication
4723-1000 IGF BP5, human recombinant Biovision 1 mg 2970 4723-1000 IGF BP5, human recombinant Biovision 1 mg 2970
ASK
Publication
4723-25 IGF-BP5, human recombinant Biovision 25 μg 247 4723-25 IGF-BP5, human recombinant Biovision 25 μg 247
ASK
Publication
4745-100 TFF-2, human recombinant Biovision 100 μg 661 4745-100 TFF-2, human recombinant Biovision 100 μg 661
ASK
Publication
4745-1000 TFF 2, human recombinant Biovision 1 mg 2919 4745-1000 TFF 2, human recombinant Biovision 1 mg 2919
ASK
Publication
4745-20 TFF-2, human recombinant Biovision 20 μg 247 4745-20 TFF-2, human recombinant Biovision 20 μg 247
ASK
Publication
4754-10 WNT-1, human recombinant Biovision 10 μg 247 4754-10 WNT-1, human recombinant Biovision 10 μg 247
ASK
Publication
4754-1000 WNT 1, human recombinant Biovision 1 mg 5120 4754-1000 WNT 1, human recombinant Biovision 1 mg 5120
ASK
Publication
4754-50 WNT-1, human recombinant Biovision 50 μg 661 4754-50 WNT-1, human recombinant Biovision 50 μg 661 Publication
4757-100 GDF-3, human recombinant Biovision 100 μg 661 4757-100 GDF-3, human recombinant Biovision 100 μg 661
ASK
Publication
4757-1000 GDF 3, human recombinant Biovision 1 mg 3635 4757-1000 GDF 3, human recombinant Biovision 1 mg 3635
ASK
Publication
4757-20 GDF-3, human recombinant Biovision 20 μg 247 4757-20 GDF-3, human recombinant Biovision 20 μg 247
ASK
Publication
4814-5 D4-GDI, human recombinant Biovision 5 μg 559 4814-5 D4-GDI, human recombinant Biovision 5 μg 559
ASK
Publication
4829-5 p53, human recombinant Biovision 5 μg 559 4829-5 p53, human recombinant Biovision 5 μg 559
ASK
Publication
4863-10 CRP, human recombinant Biovision 10 μg 236 4863-10 CRP, human recombinant Biovision 10 μg 236
ASK
Publication
4863-1000 CRP, human recombinant Biovision 1 mg 4966 4863-1000 CRP, human recombinant Biovision 1 mg 4966
ASK
Publication
4863-50 CRP, human recombinant Biovision 50 μg 559 4863-50 CRP, human recombinant Biovision 50 μg 559
ASK
Publication
4864-1000 CRP, human recombinant Biovision 1 mg 281 4864-1000 CRP, human recombinant Biovision 1 mg 281 Publication
4864-250 CRP, human recombinant Biovision 250 133 4864-250 CRP, human recombinant Biovision 250 133 Publication
4872-20 GDF-9, human recombinant Biovision 20 μg 247 4872-20 GDF-9, human recombinant Biovision 20 μg 247
ASK
Publication
4876-1000 BTC, human recombinant Biovision 1 mg 4096 4876-1000 BTC, human recombinant Biovision 1 mg 4096 Publication
4876-20 BTC, human recombinant Biovision 20 μg 252 4876-20 BTC, human recombinant Biovision 20 μg 252 Publication
4887-1000 MIA, human recombinant Biovision 1 mg 4352 4887-1000 MIA, human recombinant Biovision 1 mg 4352
ASK
Publication
4887-20 MIA, human recombinant Biovision 20 ìg 265 4887-20 MIA, human recombinant Biovision 20 ìg 265
ASK
Publication
4904-25 HIP, human recombinant Biovision 25 ug 367 4904-25 HIP, human recombinant Biovision 25 ug 367
ASK
Publication
4905-25 Hop, human recombinant Biovision 25 ug 367 4905-25 Hop, human recombinant Biovision 25 ug 367
ASK
Publication
4911-10 BMP 6, human recombinant Biovision 10 ìg 234 4911-10 BMP 6, human recombinant Biovision 10 ìg 234
ASK
Publication
4911-1000 BMP 6, human recombinant Biovision 1 mg 4096 4911-1000 BMP 6, human recombinant Biovision 1 mg 4096
ASK
Publication
4911-50 BMP 6, human recombinant Biovision 50 ìg 571 4911-50 BMP 6, human recombinant Biovision 50 ìg 571
ASK
Publication
4923-10 LIF, human recombinant Biovision 10 μg 293 4923-10 LIF, human recombinant Biovision 10 μg 293 Publication
4923-1000 LIF, human recombinant Biovision 1 mg 5376 4923-1000 LIF, human recombinant Biovision 1 mg 5376 Publication
4923-50 LIF, human recombinant Biovision 50 μg 630 4923-50 LIF, human recombinant Biovision 50 μg 630 Publication
4935-10 LBP, human recombinant Biovision 10 μg 456 4935-10 LBP, human recombinant Biovision 10 μg 456 Publication
4937-10 CD-14, human recombinant Biovision 10 μg 344 4937-10 CD-14, human recombinant Biovision 10 μg 344 Publication
4975-10 IL-24, human recombinant Biovision 10 μg 286 4975-10 IL-24, human recombinant Biovision 10 μg 286 Publication
4975-1000 IL 24, human recombinant Biovision 1 mg 8088 4975-1000 IL 24, human recombinant Biovision 1 mg 8088 Publication
4978-1000 IL 28, human recombinant Biovision 1 mg 4096 4978-1000 IL 28, human recombinant Biovision 1 mg 4096 Publication
4978-20 IL 28, human recombinant Biovision 20 ug 296 4978-20 IL 28, human recombinant Biovision 20 ug 296 Publication
4981-1000 IL 29, human recombinant Biovision 1 mg 4096 4981-1000 IL 29, human recombinant Biovision 1 mg 4096 Publication
4981-20 IL 29, human recombinant Biovision 20 ug 296 4981-20 IL 29, human recombinant Biovision 20 ug 296 Publication
4983-10 IL-31, human recombinant Biovision 10 μg 252 4983-10 IL-31, human recombinant Biovision 10 μg 252 Publication
4983-1000 IL-31, human recombinant Biovision 1 mg 5836 4983-1000 IL-31, human recombinant Biovision 1 mg 5836 Publication
4984-10 MIF, human recombinant Biovision 10 ug 347 4984-10 MIF, human recombinant Biovision 10 ug 347 Publication
4984-100 MIF, human recombinant Biovision 100 μg 866 4984-100 MIF, human recombinant Biovision 100 μg 866 Publication
4984-1000 MIF, human recombinant Biovision 1 mg 5166 4984-1000 MIF, human recombinant Biovision 1 mg 5166 Publication
4995A-100 C5a (His-Tag), human recombinant Biovision 100 μg 585.5 4995A-100 C5a (His-Tag), human recombinant Biovision 100 μg 585.5 Publication
4995A-1000 C5a (His Tag), human recombinant Biovision 1 mg 4505 4995A-1000 C5a (His Tag), human recombinant Biovision 1 mg 4505 Publication
4995A-20 Recombinant Human C5a (His Tag)20 ug Biovision 20 ug 221 4995A-20 Recombinant Human C5a (His Tag)20 ug Biovision 20 ug 221 Publication
4995B-100 C5a, human recombinant Biovision 100 μg 585.5 4995B-100 C5a, human recombinant Biovision 100 μg 585.5 Publication
4995B-1000 C5a, human recombinant Biovision 1 mg 4505 4995B-1000 C5a, human recombinant Biovision 1 mg 4505 Publication
4995B-20 C5a, human recombinant Biovision 20 ìg 250 4995B-20 C5a, human recombinant Biovision 20 ìg 250 Publication
7004-10 GSK-3b, human recombinant Biovision 10 μg 240 7004-10 GSK-3b, human recombinant Biovision 10 μg 240 Publication
7004-100 GSK 3b, human recombinant Biovision 100 ug 431 7004-100 GSK 3b, human recombinant Biovision 100 ug 431
ASK
Publication
7004-1000 GSK-3b, human recombinant Biovision 1 mg 3113 7004-1000 GSK-3b, human recombinant Biovision 1 mg 3113 Publication
7781-10 MMP 1, human recombinant Biovision 10 ug 341 7781-10 MMP 1, human recombinant Biovision 10 ug 341 Publication
7781-1000 MMP 1, human recombinant Biovision 1 mg 5120 7781-1000 MMP 1, human recombinant Biovision 1 mg 5120 Publication
7781-50 MMP 1, human recombinant Biovision 50 ug 943 7781-50 MMP 1, human recombinant Biovision 50 ug 943 Publication
7782-10 MMP-2, human recombinant Biovision 10 μg 180 7782-10 MMP-2, human recombinant Biovision 10 μg 180 Publication
7782-10 MMP 2, human recombinant Biovision 10 ug 213 7782-10 MMP 2, human recombinant Biovision 10 ug 213 Publication
7782-1000 MMP 2, human recombinant Biovision 1 mg 3635 7782-1000 MMP 2, human recombinant Biovision 1 mg 3635 Publication
7782-50 MMP-2, human recombinant Biovision 50 μg 354 7782-50 MMP-2, human recombinant Biovision 50 μg 354 Publication
7783-10 MMP-3, human recombinant Biovision 10 μg 282 7783-10 MMP-3, human recombinant Biovision 10 μg 282 Publication
7783-1000 MMP 3, human recombinant Biovision 1 mg 5120 7783-1000 MMP 3, human recombinant Biovision 1 mg 5120 Publication
7783-50 MMP 3, human recombinant Biovision 50 ug 943 7783-50 MMP 3, human recombinant Biovision 50 ug 943 Publication
7785-10 MMP-13, human recombinant Biovision 10 μg 385 7785-10 MMP-13, human recombinant Biovision 10 μg 385 Publication
7789-10 MMP-9, human recombinant Biovision 10 μg 180 7789-10 MMP-9, human recombinant Biovision 10 μg 180 Publication
7789-1000 MMP 9, human recombinant Biovision 1 mg 3635 7789-1000 MMP 9, human recombinant Biovision 1 mg 3635 Publication
7789-50 MMP-9, human recombinant Biovision 50 μg 354 7789-50 MMP-9, human recombinant Biovision 50 μg 354 Publication
DS-01-0510 Recombinant Human WNT-1 Ray Biotech 10 604 DS-01-0510 Recombinant Human WNT-1 Ray Biotech 10 604
ASK
Publication
1005-100 Annexin V, human recombinant Biovision 100 ìg 250.425 1005-100 Annexin V, human recombinant Biovision 100 ìg 250.425
ASK
Publication
1005-1000 Annexin V, human recombinant Biovision 1 mg 1445 1005-1000 Annexin V, human recombinant Biovision 1 mg 1445
ASK
Publication
1005-5000 Annexin V, human recombinant Biovision 5 mg 4545.5 1005-5000 Annexin V, human recombinant Biovision 5 mg 4545.5
ASK
Publication
1026-10 Procathepsin K, human recombinant Biovision 10 μg 286.934 1026-10 Procathepsin K, human recombinant Biovision 10 μg 286.934 Publication
1050-10 TNF-alpha, human recombinant Biovision 10 μg 139.524 1050-10 TNF-alpha, human recombinant Biovision 10 μg 139.524
ASK
Publication
1050-10 TNF alpha, human recombinant Biovision 10 ìg 127.575 1050-10 TNF alpha, human recombinant Biovision 10 ìg 127.575
ASK
Publication
1050-1000 TNF alpha, human recombinant Biovision 1 mg 1577.89 1050-1000 TNF alpha, human recombinant Biovision 1 mg 1577.89
ASK
Publication
1050-50 TNF-alpha, human recombinant Biovision 50 μg 252.126 1050-50 TNF-alpha, human recombinant Biovision 50 μg 252.126
ASK
Publication
1050-50 TNF alpha, human recombinant Biovision 50 ug 296.73 1050-50 TNF alpha, human recombinant Biovision 50 ug 296.73
ASK
Publication
1083-10 Caspase-3, human recombinant Biovision 10 μg 487.599 1083-10 Caspase-3, human recombinant Biovision 10 μg 487.599
ASK
Publication
1083-10 Caspase 3, human recombinant Biovision 10 ìg 463.995 1083-10 Caspase 3, human recombinant Biovision 10 ìg 463.995
ASK
Publication
1083-5 Caspase-3, human recombinant Biovision 5 μg 303.324 1083-5 Caspase-3, human recombinant Biovision 5 μg 303.324
ASK
Publication
1083-5 Caspase 3, human recombinant Biovision 5 ìg 282.555 1083-5 Caspase 3, human recombinant Biovision 5 ìg 282.555
ASK
Publication
1118-5 Granzyme B, human recombinant Biovision 5 ìg 357.21 1118-5 Granzyme B, human recombinant Biovision 5 ìg 357.21
ASK
Publication
1135-100 Cathepsin L, human recombinant Biovision 100 ug 430.92 1135-100 Cathepsin L, human recombinant Biovision 100 ug 430.92
ASK
Publication
1135-1000 Cathepsin L, human recombinant Biovision 1 mg 2970.19 1135-1000 Cathepsin L, human recombinant Biovision 1 mg 2970.19
ASK
Publication
1135-5 Cathepsin L, human recombinant Biovision 5 ug 174.825 1135-5 Cathepsin L, human recombinant Biovision 5 ug 174.825
ASK
Publication
157-02121 Osteoprotegerin(22 202) (OPG), Human, recombinant B-Bridge 25 ug 1118.84 157-02121 Osteoprotegerin(22 202) (OPG), Human, recombinant B-Bridge 25 ug 1118.84
ASK
Publication
157-02121 Osteoprotegerin(22 202) (OPG), Human, recombinant Osteoprotegerin(22 202) (OPG), Human, recombinant B-Bridge 25 ug 787.5 157-02121 Osteoprotegerin(22 202) (OPG), Human, recombinant Osteoprotegerin(22 202) (OPG), Human, recombinant B-Bridge 25 ug 787.5
ASK
Publication
228-10022-1 Recombinant Human Activin-A Ray Biotech 2 201 228-10022-1 Recombinant Human Activin-A Ray Biotech 2 201 Publication
228-10022-2 Recombinant Human Activin-A Ray Biotech 10 290 228-10022-2 Recombinant Human Activin-A Ray Biotech 10 290 Publication
228-10023-1 Recombinant Human Actin-Like 6A Ray Biotech 2 201 228-10023-1 Recombinant Human Actin-Like 6A Ray Biotech 2 201
ASK
Publication
228-10037-1 Recombinant Human AK2 Proteins Ray Biotech 2 147 228-10037-1 Recombinant Human AK2 Proteins Ray Biotech 2 147
ASK
Publication
228-10037-2 Recombinant Human AK2 Proteins Ray Biotech 10 205 228-10037-2 Recombinant Human AK2 Proteins Ray Biotech 10 205
ASK
Publication
228-10037-3 Recombinant Human AK2 Proteins Ray Biotech 1mg 0 228-10037-3 Recombinant Human AK2 Proteins Ray Biotech 1mg 0
ASK
Publication
228-10042-1 Recombinant Human AKT-1 Proteins Ray Biotech 2 147 228-10042-1 Recombinant Human AKT-1 Proteins Ray Biotech 2 147 Publication
228-10042-2 Recombinant Human AKT-11 Proteins Ray Biotech 10 205 228-10042-2 Recombinant Human AKT-11 Proteins Ray Biotech 10 205 Publication
228-10042-3 Recombinant Human AKT-11 Proteins Ray Biotech 1mg 0 228-10042-3 Recombinant Human AKT-11 Proteins Ray Biotech 1mg 0 Publication
228-10045-1 Recombinant Human ALK P80 Proteins Ray Biotech 2 147 228-10045-1 Recombinant Human ALK P80 Proteins Ray Biotech 2 147
ASK
Publication
228-10045-2 Recombinant Human ALK P80 Proteins Ray Biotech 5 386 228-10045-2 Recombinant Human ALK P80 Proteins Ray Biotech 5 386 Publication
228-10045-3 Recombinant Human ALK P80 Proteins Ray Biotech 10 584 228-10045-3 Recombinant Human ALK P80 Proteins Ray Biotech 10 584 Publication
228-10070-1 Recombinant Human Apolipoprotein A1 Ray Biotech 20 201 228-10070-1 Recombinant Human Apolipoprotein A1 Ray Biotech 20 201 Publication
228-10070-2 Recombinant Human Apolipoprotein A1 Ray Biotech 100 317 228-10070-2 Recombinant Human Apolipoprotein A1 Ray Biotech 100 317 Publication
228-10070-3 Recombinant Human Apolipoprotein A1 Ray Biotech 1 mg 2068 228-10070-3 Recombinant Human Apolipoprotein A1 Ray Biotech 1 mg 2068 Publication
228-10074-1 Recombinant Human Artemin Ray Biotech 5 201 228-10074-1 Recombinant Human Artemin Ray Biotech 5 201
ASK
Publication
228-10074-2 Recombinant Human Artemin Ray Biotech 20 290 228-10074-2 Recombinant Human Artemin Ray Biotech 20 290
ASK
Publication
228-10074-3 Recombinant Human Artemin Ray Biotech 1 mg 4059 228-10074-3 Recombinant Human Artemin Ray Biotech 1 mg 4059
ASK
Publication
228-10089-1 Recombinant Human BAD Proteins Ray Biotech 2 147 228-10089-1 Recombinant Human BAD Proteins Ray Biotech 2 147
ASK
Publication
228-10089-2 Recombinant Human BAD Proteins Ray Biotech 5 386 228-10089-2 Recombinant Human BAD Proteins Ray Biotech 5 386
ASK
Publication
228-10089-3 Recombinant Human BAD Proteins Ray Biotech 10 584 228-10089-3 Recombinant Human BAD Proteins Ray Biotech 10 584
ASK
Publication
228-10097-1 Recombinant Human Bcl-2 Proteins Ray Biotech 2 147 228-10097-1 Recombinant Human Bcl-2 Proteins Ray Biotech 2 147
ASK
Publication
228-10097-2 Recombinant Human Bcl-2 Proteins Ray Biotech 10 205 228-10097-2 Recombinant Human Bcl-2 Proteins Ray Biotech 10 205
ASK
Publication
228-10097-3 Recombinant Human Bcl-2 Proteins Ray Biotech 1mg 0 228-10097-3 Recombinant Human Bcl-2 Proteins Ray Biotech 1mg 0
ASK
Publication
228-10098-1 Recombinant Human Bcl-2 -BH1 Proteins Ray Biotech 2 147 228-10098-1 Recombinant Human Bcl-2 -BH1 Proteins Ray Biotech 2 147
ASK
Publication
228-10098-2 Recombinant Human Bcl-2 -BH1 Proteins Ray Biotech 10 205 228-10098-2 Recombinant Human Bcl-2 -BH1 Proteins Ray Biotech 10 205 Publication
228-10098-3 Recombinant Human Bcl-2 -BH1 Proteins Ray Biotech 1mg 0 228-10098-3 Recombinant Human Bcl-2 -BH1 Proteins Ray Biotech 1mg 0 Publication
228-10099-1 Recombinant Human Bcl-2 -BH2 Proteins Ray Biotech 2 147 228-10099-1 Recombinant Human Bcl-2 -BH2 Proteins Ray Biotech 2 147 Publication
228-10099-2 Recombinant Human Bcl-2 -BH2 Proteins Ray Biotech 10 205 228-10099-2 Recombinant Human Bcl-2 -BH2 Proteins Ray Biotech 10 205 Publication
228-10099-3 Recombinant Human Bcl-2 -BH2 Proteins Ray Biotech 1mg 0 228-10099-3 Recombinant Human Bcl-2 -BH2 Proteins Ray Biotech 1mg 0 Publication
228-10100-1 Recombinant Human Bcl-2 -BH3 Proteins Ray Biotech 2 147 228-10100-1 Recombinant Human Bcl-2 -BH3 Proteins Ray Biotech 2 147 Publication
228-10100-2 Recombinant Human Bcl-2 -BH3 Proteins Ray Biotech 10 205 228-10100-2 Recombinant Human Bcl-2 -BH3 Proteins Ray Biotech 10 205 Publication
228-10100-3 Recombinant Human Bcl-2 -BH3 Proteins Ray Biotech 1mg 0 228-10100-3 Recombinant Human Bcl-2 -BH3 Proteins Ray Biotech 1mg 0 Publication
228-10101-1 Recombinant Human Bcl-2 -BH4 Proteins Ray Biotech 2 147 228-10101-1 Recombinant Human Bcl-2 -BH4 Proteins Ray Biotech 2 147
ASK
Publication
228-10101-2 Recombinant Human Bcl-2 -BH4 Proteins Ray Biotech 10 205 228-10101-2 Recombinant Human Bcl-2 -BH4 Proteins Ray Biotech 10 205
ASK
Publication
228-10101-3 Recombinant Human Bcl-2 -BH4 Proteins Ray Biotech 1mg 0 228-10101-3 Recombinant Human Bcl-2 -BH4 Proteins Ray Biotech 1mg 0
ASK
Publication
228-10105-1 Recombinant Human Bcl-XL Proteins Ray Biotech 2 147 228-10105-1 Recombinant Human Bcl-XL Proteins Ray Biotech 2 147 Publication
228-10105-2 Recombinant Human Bcl-XL Proteins Ray Biotech 10 205 228-10105-2 Recombinant Human Bcl-XL Proteins Ray Biotech 10 205 Publication
228-10105-3 Recombinant Human Bcl-XL Proteins Ray Biotech 1mg 0 228-10105-3 Recombinant Human Bcl-XL Proteins Ray Biotech 1mg 0 Publication
228-10106-1 Recombinant Human Bcl-XL Proteins Ray Biotech 2 147 228-10106-1 Recombinant Human Bcl-XL Proteins Ray Biotech 2 147
ASK
Publication
228-10106-2 Recombinant Human Bcl-XL Proteins Ray Biotech 10 205 228-10106-2 Recombinant Human Bcl-XL Proteins Ray Biotech 10 205
ASK
Publication
228-10106-3 Recombinant Human Bcl-XL Proteins Ray Biotech 1mg 0 228-10106-3 Recombinant Human Bcl-XL Proteins Ray Biotech 1mg 0
ASK
Publication
228-10107-1 Recombinant Human Bcl-XL Proteins Ray Biotech 2 147 228-10107-1 Recombinant Human Bcl-XL Proteins Ray Biotech 2 147 Publication
228-10107-2 Recombinant Human Bcl-XL Proteins Ray Biotech 10 205 228-10107-2 Recombinant Human Bcl-XL Proteins Ray Biotech 10 205 Publication
228-10107-3 Recombinant Human Bcl-XL Proteins Ray Biotech 1mg 0 228-10107-3 Recombinant Human Bcl-XL Proteins Ray Biotech 1mg 0 Publication
228-10108-2 Recombinant Human BD1 Proteins Ray Biotech 20 205 228-10108-2 Recombinant Human BD1 Proteins Ray Biotech 20 205
ASK
Publication
228-10108-3 Recombinant Human BD1 Proteins Ray Biotech 1mg 2426 228-10108-3 Recombinant Human BD1 Proteins Ray Biotech 1mg 2426
ASK
Publication
228-10111-3 Recombinant Human BD4 Proteins Ray Biotech 1mg 2426 228-10111-3 Recombinant Human BD4 Proteins Ray Biotech 1mg 2426
ASK
Publication
228-10120-1 Recombinant Human BID Proteins Ray Biotech 2 147 228-10120-1 Recombinant Human BID Proteins Ray Biotech 2 147
ASK
Publication
228-10120-2 Recombinant Human BID Proteins Ray Biotech 10 205 228-10120-2 Recombinant Human BID Proteins Ray Biotech 10 205
ASK
Publication
228-10120-3 Recombinant Human BID Proteins Ray Biotech 1mg 0 228-10120-3 Recombinant Human BID Proteins Ray Biotech 1mg 0
ASK
Publication
228-10127-1 Recombinant Human BMF Proteins Ray Biotech 5 147 228-10127-1 Recombinant Human BMF Proteins Ray Biotech 5 147
ASK
Publication
228-10127-2 Recombinant Human BMF Proteins Ray Biotech 20 205 228-10127-2 Recombinant Human BMF Proteins Ray Biotech 20 205
ASK
Publication
228-10127-3 Recombinant Human BMF Proteins Ray Biotech 1mg 0 228-10127-3 Recombinant Human BMF Proteins Ray Biotech 1mg 0
ASK
Publication
228-10128-1 Recombinant Human BMP-2 Proteins Ray Biotech 2 147 228-10128-1 Recombinant Human BMP-2 Proteins Ray Biotech 2 147 Publication
228-10128-2 Recombinant Human BMP-2 Proteins Ray Biotech 10 205 228-10128-2 Recombinant Human BMP-2 Proteins Ray Biotech 10 205 Publication
228-10128-3 Recombinant Human BMP-2 Proteins Ray Biotech 1mg 0 228-10128-3 Recombinant Human BMP-2 Proteins Ray Biotech 1mg 0 Publication
228-10131-1 Recombinant Human BMP-4 Proteins Ray Biotech 2 147 228-10131-1 Recombinant Human BMP-4 Proteins Ray Biotech 2 147 Publication
228-10131-2 Recombinant Human BMP-4 Proteins Ray Biotech 10 205 228-10131-2 Recombinant Human BMP-4 Proteins Ray Biotech 10 205 Publication
228-10131-3 Recombinant Human BMP-4 Proteins Ray Biotech 1mg 2591 228-10131-3 Recombinant Human BMP-4 Proteins Ray Biotech 1mg 2591 Publication
228-10132-1 Recombinant Human BMP-5 Proteins Ray Biotech 5 147 228-10132-1 Recombinant Human BMP-5 Proteins Ray Biotech 5 147
ASK
Publication
228-10132-2 Recombinant Human BMP-5 Proteins Ray Biotech 20 205 228-10132-2 Recombinant Human BMP-5 Proteins Ray Biotech 20 205
ASK
Publication
228-10132-3 Recombinant Human BMP-5 Proteins Ray Biotech 1mg 2673 228-10132-3 Recombinant Human BMP-5 Proteins Ray Biotech 1mg 2673
ASK
Publication
228-10134-1 Recombinant Human BMP-7 Proteins Ray Biotech 2 147 228-10134-1 Recombinant Human BMP-7 Proteins Ray Biotech 2 147 Publication
228-10134-2 Recombinant Human BMP-7 Proteins Ray Biotech 10 205 228-10134-2 Recombinant Human BMP-7 Proteins Ray Biotech 10 205 Publication
228-10134-3 Recombinant Human BMP-7 Proteins Ray Biotech 1mg 0 228-10134-3 Recombinant Human BMP-7 Proteins Ray Biotech 1mg 0 Publication
228-10135-2 Recombinant Human BMP-7 Proteins Ray Biotech 10 205 228-10135-2 Recombinant Human BMP-7 Proteins Ray Biotech 10 205 Publication
228-10135-3 Recombinant Human BMP-7 Proteins Ray Biotech 1mg 0 228-10135-3 Recombinant Human BMP-7 Proteins Ray Biotech 1mg 0 Publication
228-10136-1 Recombinant Human BMP-7 Proteins Ray Biotech 10 147 228-10136-1 Recombinant Human BMP-7 Proteins Ray Biotech 10 147 Publication
228-10136-2 Recombinant Human BMP-7 Proteins Ray Biotech 50 205 228-10136-2 Recombinant Human BMP-7 Proteins Ray Biotech 50 205 Publication
228-10136-3 Recombinant Human BMP-7 Proteins Ray Biotech 1mg 1658 228-10136-3 Recombinant Human BMP-7 Proteins Ray Biotech 1mg 1658 Publication
228-10142-1 Recombinant Human DLX-4 BP-1 Proteins Ray Biotech 2 147 228-10142-1 Recombinant Human DLX-4 BP-1 Proteins Ray Biotech 2 147
ASK
Publication
228-10142-2 Recombinant Human DLX-4 BP-1 Proteins Ray Biotech 5 386 228-10142-2 Recombinant Human DLX-4 BP-1 Proteins Ray Biotech 5 386
ASK
Publication
228-10142-3 Recombinant Human DLX-4 BP-1 Proteins Ray Biotech 10 584 228-10142-3 Recombinant Human DLX-4 BP-1 Proteins Ray Biotech 10 584
ASK
Publication
228-10158-1 Recombinant Human Cadherin-E Ray Biotech 2 422 228-10158-1 Recombinant Human Cadherin-E Ray Biotech 2 422
ASK
Publication
228-10158-2 Recombinant Human Cadherin-E Ray Biotech 5 566 228-10158-2 Recombinant Human Cadherin-E Ray Biotech 5 566
ASK
Publication
228-10158-3 Recombinant Human Cadherin-E Ray Biotech 10 868 228-10158-3 Recombinant Human Cadherin-E Ray Biotech 10 868
ASK
Publication
228-10159-1 Recombinant Human Cadherin-N Ray Biotech 2 201 228-10159-1 Recombinant Human Cadherin-N Ray Biotech 2 201
ASK
Publication
228-10159-2 Recombinant Human Cadherin-N Ray Biotech 10 290 228-10159-2 Recombinant Human Cadherin-N Ray Biotech 10 290
ASK
Publication
228-10166-1 Recombinant Human Calmodulin Ray Biotech 10 201 228-10166-1 Recombinant Human Calmodulin Ray Biotech 10 201 Publication
228-10166-2 Recombinant Human Calmodulin Ray Biotech 50 290 228-10166-2 Recombinant Human Calmodulin Ray Biotech 50 290 Publication
228-10166-3 Recombinant Human Calmodulin Ray Biotech 1 mg 2068 228-10166-3 Recombinant Human Calmodulin Ray Biotech 1 mg 2068 Publication
228-10168-1 Recombinant Human Calumenin Ray Biotech 5 201 228-10168-1 Recombinant Human Calumenin Ray Biotech 5 201
ASK
Publication
228-10168-2 Recombinant Human Calumenin Ray Biotech 25 290 228-10168-2 Recombinant Human Calumenin Ray Biotech 25 290
ASK
Publication
228-10168-3 Recombinant Human Calumenin Ray Biotech 1 mg 3681 228-10168-3 Recombinant Human Calumenin Ray Biotech 1 mg 3681
ASK
Publication
228-10172-1 Recombinant Human CA2 Proteins Ray Biotech 5 147 228-10172-1 Recombinant Human CA2 Proteins Ray Biotech 5 147
ASK
Publication
228-10172-2 Recombinant Human CA2 Proteins Ray Biotech 20 205 228-10172-2 Recombinant Human CA2 Proteins Ray Biotech 20 205
ASK
Publication
228-10172-3 Recombinant Human CA2 Proteins Ray Biotech 1mg 0 228-10172-3 Recombinant Human CA2 Proteins Ray Biotech 1mg 0
ASK
Publication
228-10204-1 Recombinant Human CD72 Ray Biotech 2 422 228-10204-1 Recombinant Human CD72 Ray Biotech 2 422
ASK
Publication
228-10204-2 Recombinant Human CD72 Ray Biotech 5 566 228-10204-2 Recombinant Human CD72 Ray Biotech 5 566
ASK
Publication
228-10204-3 Recombinant Human CD72 Ray Biotech 10 868 228-10204-3 Recombinant Human CD72 Ray Biotech 10 868
ASK
Publication
228-10207-1 Recombinant Human CD99 Ray Biotech 2 422 228-10207-1 Recombinant Human CD99 Ray Biotech 2 422 Publication
228-10207-2 Recombinant Human CD99 Ray Biotech 5 566 228-10207-2 Recombinant Human CD99 Ray Biotech 5 566 Publication
228-10207-3 Recombinant Human CD99 Ray Biotech 10 868 228-10207-3 Recombinant Human CD99 Ray Biotech 10 868 Publication
228-10213-1 Recombinant Human CEA Proteins Ray Biotech 2 147 228-10213-1 Recombinant Human CEA Proteins Ray Biotech 2 147 Publication
228-10213-2 Recombinant Human CEA Proteins Ray Biotech 10 205 228-10213-2 Recombinant Human CEA Proteins Ray Biotech 10 205 Publication
228-10213-3 Recombinant Human CEA Proteins Ray Biotech 1mg 0 228-10213-3 Recombinant Human CEA Proteins Ray Biotech 1mg 0 Publication
228-10218-1 Recombinant Human c-erbB2 Ray Biotech 2 422 228-10218-1 Recombinant Human c-erbB2 Ray Biotech 2 422
ASK
Publication
228-10218-2 Recombinant Human c-erbB2 Ray Biotech 5 566 228-10218-2 Recombinant Human c-erbB2 Ray Biotech 5 566
ASK
Publication
228-10218-3 Recombinant Human c-erbB2 Ray Biotech 10 868 228-10218-3 Recombinant Human c-erbB2 Ray Biotech 10 868
ASK
Publication
228-10220-1 Recombinant Human Cofilin-1 Ray Biotech 5 201 228-10220-1 Recombinant Human Cofilin-1 Ray Biotech 5 201
ASK
Publication
228-10220-2 Recombinant Human Cofilin-1 Ray Biotech 20 290 228-10220-2 Recombinant Human Cofilin-1 Ray Biotech 20 290
ASK
Publication
228-10264-1 Recombinant Human Like Collagen Ray Biotech 100 mg 449 228-10264-1 Recombinant Human Like Collagen Ray Biotech 100 mg 449 Publication
228-10264-2 Recombinant Human Like Collagen Ray Biotech 500 mg 1297 228-10264-2 Recombinant Human Like Collagen Ray Biotech 500 mg 1297 Publication
228-10264-3 Recombinant Human Like Collagen Ray Biotech 1 g 2068 228-10264-3 Recombinant Human Like Collagen Ray Biotech 1 g 2068 Publication
228-10265-1 Recombinant Human Collagen-1 Ray Biotech 10 mg 449 228-10265-1 Recombinant Human Collagen-1 Ray Biotech 10 mg 449
ASK
Publication
228-10266-1 Recombinant Human Collagen-3 Ray Biotech 10 mg 449 228-10266-1 Recombinant Human Collagen-3 Ray Biotech 10 mg 449 Publication
228-10266-2 Recombinant Human Collagen-3 Ray Biotech 50 mg 1297 228-10266-2 Recombinant Human Collagen-3 Ray Biotech 50 mg 1297 Publication
228-10266-3 Recombinant Human Collagen-3 Ray Biotech 100 mg 2068 228-10266-3 Recombinant Human Collagen-3 Ray Biotech 100 mg 2068 Publication
228-10272-1 Recombinant Human Complexin-1 Ray Biotech 10 201 228-10272-1 Recombinant Human Complexin-1 Ray Biotech 10 201
ASK
Publication
228-10279-1 Recombinant Human CRP Proteins Ray Biotech 500 147 228-10279-1 Recombinant Human CRP Proteins Ray Biotech 500 147 Publication
228-10279-2 Recombinant Human CRP Proteins Ray Biotech 1mg 411 228-10279-2 Recombinant Human CRP Proteins Ray Biotech 1mg 411 Publication
228-10279-3 Recombinant Human CRP Proteins Ray Biotech 5mg 1370 228-10279-3 Recombinant Human CRP Proteins Ray Biotech 5mg 1370 Publication
228-10285-3 Recombinant Human C-SRC Proteins Ray Biotech 1mg 0 228-10285-3 Recombinant Human C-SRC Proteins Ray Biotech 1mg 0 Publication
228-10294-1 Recombinant Human Cyclophilin-A Ray Biotech 10 201 228-10294-1 Recombinant Human Cyclophilin-A Ray Biotech 10 201
ASK
Publication
228-10294-2 Recombinant Human Cyclophilin-A Ray Biotech 50 290 228-10294-2 Recombinant Human Cyclophilin-A Ray Biotech 50 290
ASK
Publication
228-10294-3 Recombinant Human Cyclophilin-A Ray Biotech 1 mg 2194 228-10294-3 Recombinant Human Cyclophilin-A Ray Biotech 1 mg 2194
ASK
Publication
228-10295-1 Recombinant Human Cyclophilin-B Ray Biotech 20 201 228-10295-1 Recombinant Human Cyclophilin-B Ray Biotech 20 201 Publication
228-10295-2 Recombinant Human Cyclophilin-B Ray Biotech 100 290 228-10295-2 Recombinant Human Cyclophilin-B Ray Biotech 100 290 Publication
228-10295-3 Recombinant Human Cyclophilin-B Ray Biotech 1 mg 1551 228-10295-3 Recombinant Human Cyclophilin-B Ray Biotech 1 mg 1551 Publication
228-10296-1 Recombinant Human Cyclophilin-D Ray Biotech 5 201 228-10296-1 Recombinant Human Cyclophilin-D Ray Biotech 5 201
ASK
Publication
228-10296-2 Recombinant Human Cyclophilin-D Ray Biotech 20 290 228-10296-2 Recombinant Human Cyclophilin-D Ray Biotech 20 290
ASK
Publication
228-10297-1 Recombinant Human Cyclophilin-E Ray Biotech 5 201 228-10297-1 Recombinant Human Cyclophilin-E Ray Biotech 5 201
ASK
Publication
228-10297-2 Recombinant Human Cyclophilin-E Ray Biotech 25 290 228-10297-2 Recombinant Human Cyclophilin-E Ray Biotech 25 290
ASK
Publication
228-10297-3 Recombinant Human Cyclophilin-E Ray Biotech 1 mg 3933 228-10297-3 Recombinant Human Cyclophilin-E Ray Biotech 1 mg 3933
ASK
Publication
228-10301-2 Recombinant Human Cystatin C Ray Biotech 25 290 228-10301-2 Recombinant Human Cystatin C Ray Biotech 25 290 Publication
228-10301-3 Recombinant Human Cystatin C Ray Biotech 1 mg 3202 228-10301-3 Recombinant Human Cystatin C Ray Biotech 1 mg 3202 Publication
228-10322-1 Recombinant Human Desmin Ray Biotech 5 201 228-10322-1 Recombinant Human Desmin Ray Biotech 5 201
ASK
Publication
228-10322-2 Recombinant Human Desmin Ray Biotech 20 290 228-10322-2 Recombinant Human Desmin Ray Biotech 20 290
ASK
Publication
228-10324-1 Recombinant Human DHH Proteins Ray Biotech 5 205 228-10324-1 Recombinant Human DHH Proteins Ray Biotech 5 205
ASK
Publication
228-10324-2 Recombinant Human DHH Proteins Ray Biotech 25 275 228-10324-2 Recombinant Human DHH Proteins Ray Biotech 25 275
ASK
Publication
228-10324-3 Recombinant Human DHH Proteins Ray Biotech 1mg 2591 228-10324-3 Recombinant Human DHH Proteins Ray Biotech 1mg 2591
ASK
Publication
228-10360-1 Recombinant Human EGF Proteins Ray Biotech 100 147 228-10360-1 Recombinant Human EGF Proteins Ray Biotech 100 147 Publication
228-10360-2 Recombinant Human EGF Proteins Ray Biotech 500 205 228-10360-2 Recombinant Human EGF Proteins Ray Biotech 500 205 Publication
228-10360-3 Recombinant Human EGF Proteins Ray Biotech 1mg 318 228-10360-3 Recombinant Human EGF Proteins Ray Biotech 1mg 318 Publication
228-10365-1 Recombinant Human EGF (Leu 21) Proteins Ray Biotech 20 147 228-10365-1 Recombinant Human EGF (Leu 21) Proteins Ray Biotech 20 147
ASK
Publication
228-10365-2 Recombinant Human EGF (Leu 21) Proteins Ray Biotech 100 205 228-10365-2 Recombinant Human EGF (Leu 21) Proteins Ray Biotech 100 205
ASK
Publication
228-10365-3 Recombinant Human EGF (Leu 21) Proteins Ray Biotech 1mg 961 228-10365-3 Recombinant Human EGF (Leu 21) Proteins Ray Biotech 1mg 961
ASK
Publication
228-10366-1 Recombinant Human EGF Proteins Ray Biotech 100 147 228-10366-1 Recombinant Human EGF Proteins Ray Biotech 100 147
ASK
Publication
228-10366-2 Recombinant Human EGF Proteins Ray Biotech 500 205 228-10366-2 Recombinant Human EGF Proteins Ray Biotech 500 205
ASK
Publication
228-10366-3 Recombinant Human EGF Proteins Ray Biotech 1mg 353 228-10366-3 Recombinant Human EGF Proteins Ray Biotech 1mg 353
ASK
Publication
228-10373-3 Recombinant Human ELK-1 Proteins Ray Biotech 1mg 0 228-10373-3 Recombinant Human ELK-1 Proteins Ray Biotech 1mg 0 Publication
228-10386-1 Recombinant Human Endoglin Ray Biotech 2 422 228-10386-1 Recombinant Human Endoglin Ray Biotech 2 422
ASK
Publication
228-10386-2 Recombinant Human Endoglin Ray Biotech 5 566 228-10386-2 Recombinant Human Endoglin Ray Biotech 5 566
ASK
Publication
228-10386-3 Recombinant Human Endoglin Ray Biotech 10 868 228-10386-3 Recombinant Human Endoglin Ray Biotech 10 868
ASK
Publication
228-10389-1 Recombinant Human Endostatin Ray Biotech 20 201 228-10389-1 Recombinant Human Endostatin Ray Biotech 20 201 Publication
228-10389-2 Recombinant Human Endostatin Ray Biotech 100 290 228-10389-2 Recombinant Human Endostatin Ray Biotech 100 290 Publication
228-10389-3 Recombinant Human Endostatin Ray Biotech 1 mg 1551 228-10389-3 Recombinant Human Endostatin Ray Biotech 1 mg 1551 Publication
228-10400-1 Recombinant Human Epigen Ray Biotech 5 201 228-10400-1 Recombinant Human Epigen Ray Biotech 5 201
ASK
Publication
228-10400-2 Recombinant Human Epigen Ray Biotech 25 290 228-10400-2 Recombinant Human Epigen Ray Biotech 25 290
ASK
Publication
228-10400-3 Recombinant Human Epigen Ray Biotech 1 mg 3681 228-10400-3 Recombinant Human Epigen Ray Biotech 1 mg 3681
ASK
Publication
228-10402-1 Recombinant Human Ephrin A4 Ray Biotech 2 422 228-10402-1 Recombinant Human Ephrin A4 Ray Biotech 2 422
ASK
Publication
228-10402-2 Recombinant Human Ephrin A4 Ray Biotech 5 566 228-10402-2 Recombinant Human Ephrin A4 Ray Biotech 5 566
ASK
Publication
228-10402-3 Recombinant Human Ephrin A4 Ray Biotech 10 868 228-10402-3 Recombinant Human Ephrin A4 Ray Biotech 10 868
ASK
Publication
228-10403-1 Recombinant Human Ephrin B1 Ray Biotech 2 422 228-10403-1 Recombinant Human Ephrin B1 Ray Biotech 2 422
ASK
Publication
228-10403-2 Recombinant Human Ephrin B1 Ray Biotech 5 566 228-10403-2 Recombinant Human Ephrin B1 Ray Biotech 5 566
ASK
Publication
228-10403-3 Recombinant Human Ephrin B1 Ray Biotech 10 868 228-10403-3 Recombinant Human Ephrin B1 Ray Biotech 10 868
ASK
Publication
228-10404-1 Recombinant Human Ephrin B3 Ray Biotech 2 422 228-10404-1 Recombinant Human Ephrin B3 Ray Biotech 2 422
ASK
Publication
228-10404-2 Recombinant Human Ephrin B3 Ray Biotech 5 566 228-10404-2 Recombinant Human Ephrin B3 Ray Biotech 5 566
ASK
Publication
228-10404-3 Recombinant Human Ephrin B3 Ray Biotech 10 868 228-10404-3 Recombinant Human Ephrin B3 Ray Biotech 10 868
ASK
Publication
228-10411-1 Recombinant Human Epiregulin Ray Biotech 5 201 228-10411-1 Recombinant Human Epiregulin Ray Biotech 5 201 Publication
228-10411-2 Recombinant Human Epiregulin Ray Biotech 25 290 228-10411-2 Recombinant Human Epiregulin Ray Biotech 25 290 Publication
228-10411-3 Recombinant Human Epiregulin Ray Biotech 1 mg 3681 228-10411-3 Recombinant Human Epiregulin Ray Biotech 1 mg 3681 Publication
228-10416-1 Recombinant Human E-Selectin Ray Biotech 2 201 228-10416-1 Recombinant Human E-Selectin Ray Biotech 2 201
ASK
Publication
228-10416-2 Recombinant Human E-Selectin Ray Biotech 10 290 228-10416-2 Recombinant Human E-Selectin Ray Biotech 10 290
ASK
Publication
228-10498-1 Recombinant Human FST Proteins Ray Biotech 5 147 228-10498-1 Recombinant Human FST Proteins Ray Biotech 5 147 Publication
228-10498-2 Recombinant Human FST Proteins Ray Biotech 20 205 228-10498-2 Recombinant Human FST Proteins Ray Biotech 20 205 Publication
228-10498-3 Recombinant Human FST Proteins Ray Biotech 1mg 0 228-10498-3 Recombinant Human FST Proteins Ray Biotech 1mg 0 Publication
228-10518-1 Recombinant Human GCK Proteins Ray Biotech 2 188 228-10518-1 Recombinant Human GCK Proteins Ray Biotech 2 188 Publication
228-10518-2 Recombinant Human GCK Proteins Ray Biotech 10 205 228-10518-2 Recombinant Human GCK Proteins Ray Biotech 10 205 Publication
228-10518-3 Recombinant Human GCK Proteins Ray Biotech 1mg 0 228-10518-3 Recombinant Human GCK Proteins Ray Biotech 1mg 0 Publication
228-10524-1 Recombinant Human Gelatin Ray Biotech 10 mg 422 228-10524-1 Recombinant Human Gelatin Ray Biotech 10 mg 422 Publication
228-10524-2 Recombinant Human Gelatin Ray Biotech 50 mg 793 228-10524-2 Recombinant Human Gelatin Ray Biotech 50 mg 793 Publication
228-10524-3 Recombinant Human Gelatin Ray Biotech 100 mg 1146 228-10524-3 Recombinant Human Gelatin Ray Biotech 100 mg 1146 Publication
228-10532-1 Recombinant Human GH Proteins Ray Biotech 100 205 228-10532-1 Recombinant Human GH Proteins Ray Biotech 100 205 Publication
228-10532-2 Recombinant Human GH Proteins Ray Biotech 500 353 228-10532-2 Recombinant Human GH Proteins Ray Biotech 500 353 Publication
228-10532-3 Recombinant Human GH Proteins Ray Biotech 1mg 485 228-10532-3 Recombinant Human GH Proteins Ray Biotech 1mg 485 Publication
228-10548-1 Recombinant Human Glyoxalase-I Ray Biotech 10 201 228-10548-1 Recombinant Human Glyoxalase-I Ray Biotech 10 201
ASK
Publication
228-10548-2 Recombinant Human Glyoxalase-I Ray Biotech 50 290 228-10548-2 Recombinant Human Glyoxalase-I Ray Biotech 50 290
ASK
Publication
228-10548-3 Recombinant Human Glyoxalase-I Ray Biotech 1 mg 2509 228-10548-3 Recombinant Human Glyoxalase-I Ray Biotech 1 mg 2509
ASK
Publication
228-10560-1 Recombinant Human Geminin Ray Biotech 5 201 228-10560-1 Recombinant Human Geminin Ray Biotech 5 201
ASK
Publication
228-10568-1 Recombinant Human GPI Proteins Ray Biotech 5 147 228-10568-1 Recombinant Human GPI Proteins Ray Biotech 5 147 Publication
228-10568-2 Recombinant Human GPI Proteins Ray Biotech 20 205 228-10568-2 Recombinant Human GPI Proteins Ray Biotech 20 205 Publication
228-10568-3 Recombinant Human GPI Proteins Ray Biotech 1mg 2426 228-10568-3 Recombinant Human GPI Proteins Ray Biotech 1mg 2426 Publication
228-10583-1 Recombinant Human Glutaredoxin 1 Ray Biotech 10 201 228-10583-1 Recombinant Human Glutaredoxin 1 Ray Biotech 10 201
ASK
Publication
228-10593-1 Recombinant Human Prouroguanylin Ray Biotech 2 201 228-10593-1 Recombinant Human Prouroguanylin Ray Biotech 2 201 Publication
228-10595-1 Recombinant Human Haptoglobin Ray Biotech 5 201 228-10595-1 Recombinant Human Haptoglobin Ray Biotech 5 201
ASK
Publication
228-10595-2 Recombinant Human Haptoglobin Ray Biotech 20 290 228-10595-2 Recombinant Human Haptoglobin Ray Biotech 20 290
ASK
Publication
228-10595-3 Recombinant Human Haptoglobin Ray Biotech 1 mg 3202 228-10595-3 Recombinant Human Haptoglobin Ray Biotech 1 mg 3202
ASK
Publication
228-10702-1 Recombinant Human HGF [from Sf9] Proteins Ray Biotech 2 147 228-10702-1 Recombinant Human HGF [from Sf9] Proteins Ray Biotech 2 147 Publication
228-10702-2 Recombinant Human HGF [from Sf9] Proteins Ray Biotech 10 205 228-10702-2 Recombinant Human HGF [from Sf9] Proteins Ray Biotech 10 205 Publication
228-10702-3 Recombinant Human HGF [from Sf9] Proteins Ray Biotech 1mg 0 228-10702-3 Recombinant Human HGF [from Sf9] Proteins Ray Biotech 1mg 0 Publication
228-10763-1 Recombinant Human HK-1 Proteins Ray Biotech 2 147 228-10763-1 Recombinant Human HK-1 Proteins Ray Biotech 2 147
ASK
Publication
228-10763-2 Recombinant Human HK-1 Proteins Ray Biotech 10 205 228-10763-2 Recombinant Human HK-1 Proteins Ray Biotech 10 205
ASK
Publication
228-10763-3 Recombinant Human HK-1 Proteins Ray Biotech 1mg 0 228-10763-3 Recombinant Human HK-1 Proteins Ray Biotech 1mg 0
ASK
Publication
228-10764-1 Recombinant Human Hexokinase-2 Ray Biotech 2 201 228-10764-1 Recombinant Human Hexokinase-2 Ray Biotech 2 201 Publication
228-10764-2 Recombinant Human Hexokinase-2 Ray Biotech 10 290 228-10764-2 Recombinant Human Hexokinase-2 Ray Biotech 10 290 Publication
228-10764-3 Recombinant Human HK-2 Proteins Ray Biotech 1mg 0 228-10764-3 Recombinant Human HK-2 Proteins Ray Biotech 1mg 0 Publication
228-10765-1 Recombinant Human Hexokinase-3 Ray Biotech 2 201 228-10765-1 Recombinant Human Hexokinase-3 Ray Biotech 2 201
ASK
Publication
228-10765-2 Recombinant Human HK-3 Proteins Ray Biotech 10 205 228-10765-2 Recombinant Human HK-3 Proteins Ray Biotech 10 205
ASK
Publication
228-10765-3 Recombinant Human HK-3 Proteins Ray Biotech 1mg 0 228-10765-3 Recombinant Human HK-3 Proteins Ray Biotech 1mg 0
ASK
Publication
228-10809-1 Recombinant Human I-309 CCL1 Ray Biotech 2 201 228-10809-1 Recombinant Human I-309 CCL1 Ray Biotech 2 201 Publication
228-10810-1 Recombinant Human I-TAC CXCL11 Ray Biotech 5 201 228-10810-1 Recombinant Human I-TAC CXCL11 Ray Biotech 5 201
ASK
Publication
228-10858-1 Recombinant Human IL-10 [+His] Proteins Ray Biotech 2 147 228-10858-1 Recombinant Human IL-10 [+His] Proteins Ray Biotech 2 147
ASK
Publication
228-10858-2 Recombinant Human IL-10 [+His] Proteins Ray Biotech 10 205 228-10858-2 Recombinant Human IL-10 [+His] Proteins Ray Biotech 10 205
ASK
Publication
228-10858-3 Recombinant Human IL-10 [+His] Proteins Ray Biotech 1mg 0 228-10858-3 Recombinant Human IL-10 [+His] Proteins Ray Biotech 1mg 0
ASK
Publication
228-10859-1 Recombinant Human Interleukin-11 (IL-11) Ray Biotech 2 201 228-10859-1 Recombinant Human Interleukin-11 (IL-11) Ray Biotech 2 201 Publication
228-10859-2 Recombinant Human Interleukin-11 (IL-11) Ray Biotech 10 290 228-10859-2 Recombinant Human Interleukin-11 (IL-11) Ray Biotech 10 290 Publication
228-10859-3 Recombinant Human IL-11 Proteins Ray Biotech 1mg 0 228-10859-3 Recombinant Human IL-11 Proteins Ray Biotech 1mg 0 Publication
228-10865-1 Recombinant Human IL-13 Proteins Ray Biotech 2 147 228-10865-1 Recombinant Human IL-13 Proteins Ray Biotech 2 147
ASK
Publication
228-10865-2 Recombinant Human IL-13 Proteins Ray Biotech 10 205 228-10865-2 Recombinant Human IL-13 Proteins Ray Biotech 10 205
ASK
Publication
228-10865-3 Recombinant Human IL-13 Proteins Ray Biotech 1mg 0 228-10865-3 Recombinant Human IL-13 Proteins Ray Biotech 1mg 0
ASK
Publication
228-10868-1 Recombinant Human IL-13 [+His] Proteins Ray Biotech 2 147 228-10868-1 Recombinant Human IL-13 [+His] Proteins Ray Biotech 2 147
ASK
Publication
228-10868-2 Recombinant Human IL-13 [+His] Proteins Ray Biotech 10 205 228-10868-2 Recombinant Human IL-13 [+His] Proteins Ray Biotech 10 205
ASK
Publication
228-10868-3 Recombinant Human IL-13 [+His] Proteins Ray Biotech 1mg 0 228-10868-3 Recombinant Human IL-13 [+His] Proteins Ray Biotech 1mg 0
ASK
Publication
228-10869-1 Recombinant Human Interleukin-15 (IL-15) Ray Biotech 2 201 228-10869-1 Recombinant Human Interleukin-15 (IL-15) Ray Biotech 2 201
ASK
Publication
228-10869-2 Recombinant Human Interleukin-15 (IL-15) Ray Biotech 10 290 228-10869-2 Recombinant Human Interleukin-15 (IL-15) Ray Biotech 10 290
ASK
Publication
228-10869-3 Recombinant Human IL-15 Proteins Ray Biotech 1mg 0 228-10869-3 Recombinant Human IL-15 Proteins Ray Biotech 1mg 0
ASK
Publication
228-10873-1 Recombinant Human IL-15 [+His] Proteins Ray Biotech 2 147 228-10873-1 Recombinant Human IL-15 [+His] Proteins Ray Biotech 2 147
ASK
Publication
228-10873-2 Recombinant Human IL-15 [+His] Proteins Ray Biotech 10 205 228-10873-2 Recombinant Human IL-15 [+His] Proteins Ray Biotech 10 205
ASK
Publication
228-10873-3 Recombinant Human IL-15 [+His] Proteins Ray Biotech 1mg 0 228-10873-3 Recombinant Human IL-15 [+His] Proteins Ray Biotech 1mg 0
ASK
Publication
228-10875-1 Recombinant Human Interleukin-16 (IL-16) Ray Biotech 2 201 228-10875-1 Recombinant Human Interleukin-16 (IL-16) Ray Biotech 2 201 Publication
228-10875-2 Recombinant Human Interleukin-16 (IL-16) Ray Biotech 10 290 228-10875-2 Recombinant Human Interleukin-16 (IL-16) Ray Biotech 10 290 Publication
228-10875-3 Recombinant Human IL-16 Proteins Ray Biotech 1mg 0 228-10875-3 Recombinant Human IL-16 Proteins Ray Biotech 1mg 0 Publication
228-10877-1 Recombinant Human IL-16 [+His] Proteins Ray Biotech 5 147 228-10877-1 Recombinant Human IL-16 [+His] Proteins Ray Biotech 5 147 Publication
228-10877-2 Recombinant Human IL-16 [+His] Proteins Ray Biotech 25 205 228-10877-2